<SEC-DOCUMENT>0001193125-24-135360.txt : 20240509
<SEC-HEADER>0001193125-24-135360.hdr.sgml : 20240509
<ACCEPTANCE-DATETIME>20240509165902
ACCESSION NUMBER:		0001193125-24-135360
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20240506
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240509
DATE AS OF CHANGE:		20240509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KELLANOVA
		CENTRAL INDEX KEY:			0000055067
		STANDARD INDUSTRIAL CLASSIFICATION:	GRAIN MILL PRODUCTS [2040]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				380710690
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-04171
		FILM NUMBER:		24931664

	BUSINESS ADDRESS:	
		STREET 1:		412 N WELLS ST
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60654
		BUSINESS PHONE:		2699612000

	MAIL ADDRESS:	
		STREET 1:		412 N WELLS ST
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60654

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KELLOGG CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d804742d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:k="http://kellanova.com/20240506" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-303">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-05-06_to_2024-05-06">0000055067</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="k-20240506.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-05-06_to_2024-05-06"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000055067</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-05-06</xbrli:startDate> <xbrli:endDate>2024-05-06</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000055067</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-05-06</xbrli:startDate> <xbrli:endDate>2024-05-06</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.000SeniorNotesDue2024Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000055067</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">k:A1.000SeniorNotesDue2024Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-05-06</xbrli:startDate> <xbrli:endDate>2024-05-06</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.250SeniorNotesDue2025Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000055067</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">k:A1.250SeniorNotesDue2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-05-06</xbrli:startDate> <xbrli:endDate>2024-05-06</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-FiveZeroPercentEuroNotesDueTwentyTwentyNineMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000055067</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">k:FiveZeroPercentEuroNotesDueTwentyTwentyNineMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-05-06</xbrli:startDate> <xbrli:endDate>2024-05-06</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, DC 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-346">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-05-06_to_2024-05-06" format="ixt:datemonthdayyearen" id="ixv-347">May&#160;6, 2024</ix:nonNumeric></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-348">Kellanova</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-05-06_to_2024-05-06" format="ixt-sec:stateprovnameen" id="ixv-349">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-350">1-4171</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-351">38-0710690</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:99%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-352">412 N. Wells Street</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-353">Chicago</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-05-06_to_2024-05-06" format="ixt-sec:stateprovnameen" id="ixv-354">Illinois</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-355">60654</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices, including zip code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-356">(269)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-357">961-2000</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-05-06_to_2024-05-06" format="ixt-sec:boolballotbox" id="ixv-358">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-05-06_to_2024-05-06" format="ixt-sec:boolballotbox" id="ixv-359">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-05-06_to_2024-05-06" format="ixt-sec:boolballotbox" id="ixv-360">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-05-06_to_2024-05-06" format="ixt-sec:boolballotbox" id="ixv-361">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" id="ixv-362">Common Stock, $.25 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" id="ixv-363">K</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen" id="ixv-364">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.000SeniorNotesDue2024Member" id="ixv-365">1.000% Senior Notes due 2024</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.000SeniorNotesDue2024Member" id="ixv-366">K 24</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.000SeniorNotesDue2024Member" format="ixt-sec:exchnameen" id="ixv-367">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.250SeniorNotesDue2025Member" id="ixv-368">1.250% Senior Notes due 2025</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.250SeniorNotesDue2025Member" id="ixv-369">K 25</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.250SeniorNotesDue2025Member" format="ixt-sec:exchnameen" id="ixv-370">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-FiveZeroPercentEuroNotesDueTwentyTwentyNineMember" id="ixv-371">0.500% Senior Notes due 2029</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-FiveZeroPercentEuroNotesDueTwentyTwentyNineMember" id="ixv-372">K 29</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-FiveZeroPercentEuroNotesDueTwentyTwentyNineMember" format="ixt-sec:exchnameen" id="ixv-373">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (17 CFR <span style="white-space:nowrap">&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-05-06_to_2024-05-06" format="ixt-sec:boolballotbox" id="ixv-374">&#9744;</ix:nonNumeric>&#8194;Emerging Growth Company</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;1.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Indenture </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&#160;6, 2024, Kellanova (the &#8220;Company&#8221;) entered into an indenture with U.S. Bank Trust Company, National Association, as trustee (the &#8220;Indenture&#8221;), which provides for the issuance of debt securities by the Company, and pursuant to which the Company will issue the Notes (as defined below). The Indenture contains covenants limiting, among other things and subject to certain exceptions, the ability of the Company and its Restricted Subsidiaries (as defined therein) to: incur debt that is secured by a Principal Property (as defined therein) or stock or debt of a Restricted Subsidiary; or enter into a sale and lease-back transaction of any Principal Property. The terms of the Indenture contain customary events of default with respect to any series of debt securities, including: default for 30 days in payment of interest; default in payment of principal (or premium, if any); failure to comply with the covenants or agreements in the Indenture; and certain events of bankruptcy, insolvency or reorganization. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The description of the Indenture in this Current Report on Form <span style="white-space:nowrap">8-K</span> is qualified in its entirety by reference to the complete text of the Indenture, a copy of which is filed as Exhibit 4.1 hereto and is incorporated herein by reference. </p> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">Underwriting Agreements </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&#160;6, 2024, the Company priced an offering of $300,000,000 of 5.750% Senior Notes due 2054 (the &#8220;USD Notes&#8221;). In connection with such offering, the Company entered into an Underwriting Agreement, dated as of May&#160;6, 2024 (the &#8220;USD Underwriting Agreement&#8221;), with Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Morgan Stanley&#160;&amp; Co. LLC, as representatives of the several underwriters named therein. The USD Notes were registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), pursuant to the Company&#8217;s Registration Statement on Form <span style="white-space:nowrap">S-3</span> (File <span style="white-space:nowrap">No.&#160;333-279131)</span> filed with the U.S. Securities and Exchange Commission (the &#8220;Commission&#8221;) on May&#160;6, 2024 (the &#8220;Registration Statement&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&#160;7, 2024, the Company filed with the Commission a Prospectus Supplement, dated as of May&#160;6, 2024 (the &#8220;USD Prospectus Supplement&#8221;), in connection with the public offering of the USD Notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&#160;7, 2024, the Company priced an offering of &#8364;300,000,000 of 3.750% Senior Notes due 2034 (the &#8220;EUR Notes&#8221; and, together with the USD Notes, the &#8220;Notes&#8221;). In connection with such offering, the Company entered into an Underwriting Agreement, dated as of May&#160;7, 2024 (together with the USD Underwriting Agreement, the &#8220;Underwriting Agreements&#8221;), with Barclays Bank PLC, Merrill Lynch International and Co&#246;peratieve Rabobank U.A., as representatives of the several underwriters named therein. The EUR Notes were registered under the Securities Act pursuant to the Registration Statement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&#160;8, 2024, the Company filed with the Commission a Prospectus Supplement, dated as of May&#160;7, 2024 (together with the USD Prospectus Supplement, the &#8220;Prospectus Supplements&#8221;) in connection with the public offering of the EUR Notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For a complete description of the terms and conditions of the Underwriting Agreements, please refer to the Prospectus Supplements and the copies of the Underwriting Agreements, which are filed as exhibits 1.1 and 1.2 hereto and are incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain of the underwriters and their respective affiliates have, from time to time, performed, and may in the future perform, various financial advisory and investment banking services for the Company, for which they received or will receive customary fees and expenses. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:98%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:89%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap">Exhibit<br/>No.</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit&#160;1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d804742dex11.htm">Underwriting Agreement, dated May&#160;6, 2024, by and among Kellanova, Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Morgan Stanley&#160;&amp; Co. LLC. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit&#160;1.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d804742dex12.htm">Underwriting Agreement, dated May&#160;7, 2024, by and among Kellanova, Barclays Bank PLC, Merrill Lynch International and Co&#246;peratieve Rabobank U.A. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit&#160;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/55067/000119312524131477/d828383dex41.htm">Indenture, dated May&#160;6, 2024, between Kellanova and U.S. Bank Trust Company, National Association, incorporated by reference to Exhibit&#160;4.1 to the Company&#8217;s Registration Statement, Commission on Form <span style="white-space:nowrap">S-3</span> (File <span style="white-space:nowrap">No.&#160;333-279131).</span></a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit&#160;104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (formatted as inline XBRL).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">SIGNATURES </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:5%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:44%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">KELLANOVA</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="4"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: May&#160;9, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John Min</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">John Min</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Legal Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d804742dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Execution Version </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$300,000,000 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KELLANOVA
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>5.750% Senior Notes due 2054 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Underwriting Agreement </U></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May&nbsp;6,
2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities
LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As representatives
of the Several Underwriters </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Citigroup Global Markets Inc. </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">388 Greenwich Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">New York,
NY 10013 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">383 Madison Avenue, </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">New York, NY
10179 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">1585 Broadway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">New York, NY 10036
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kellanova, a
Delaware corporation (the &#147;Company&#148;), proposes to issue and sell to the several Underwriters listed in Schedule&nbsp;1 hereto (the &#147;Underwriters&#148;), for whom you are acting as representatives (the &#147;Representatives&#148;),
$300,000,000 aggregate principal amount of its 5.750% Senior Notes due 2054 (the &#147;Securities&#148;). The Securities will be issued pursuant to an Indenture, dated as of May&nbsp;6, 2024 (the &#147;Indenture&#148;), between the Company and U.S.
Bank Trust Company, National Association, as trustee (the &#147;Trustee&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Registration Statement</U>. The Company has
prepared and filed with the Securities and Exchange Commission (the &#147;Commission&#148;) under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#147;Securities Act&#148;), a
registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-279131),</FONT> including a prospectus (the &#147;Basic Prospectus&#148;), relating to the debt securities to be
issued from time to time by the Company. The Registration Statement (as defined below) is an &#147;automatic shelf registration statement,&#148; as </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
defined in Rule 405 of the Act, that automatically became effective not more than three years prior to the date hereof. The Company has also filed, or proposes to file, with the Commission
pursuant to Rule&nbsp;424 under the Securities Act a prospectus supplement specifically relating to the Securities (the &#147;Prospectus Supplement&#148;). The registration statement, as amended at the time it becomes effective, including the
information, if any, deemed pursuant to Rule&nbsp;430A, 430B or 430C under the Securities Act to be part of the registration statement at the time of its effectiveness (&#147;Rule&nbsp;430 Information&#148;), is referred to herein as the
&#147;Registration Statement.&#148; As used herein, the term &#147;Prospectus&#148; means the Basic Prospectus as supplemented by the prospectus supplement specifically relating to the Securities in the form first used to confirm sales (or made
available upon request of purchasers pursuant to Rule 173 under the Securities Act) of the Securities and the term &#147;Preliminary Prospectus&#148; means the preliminary prospectus supplement, if any, specifically relating to the Securities
together with the Basic Prospectus. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Registration Statement and the Prospectus. References herein to the Registration Statement, the Basic Prospectus,
any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein. The terms &#147;supplement,&#148; &#147;amendment&#148; and &#147;amend&#148; as used herein with respect to the
Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any documents filed by the Company under the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission
thereunder (the &#147;Exchange Act&#148;) subsequent to the date of this Underwriting Agreement which are deemed to be incorporated by reference therein. For purposes of this Underwriting Agreement, the term &#147;Effective Time&#148; means each
effective date of the Registration Statement with respect to the offering of Securities, as determined for purposes of Section&nbsp;11 of the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At or prior to 2:30 P.M., New York City time, on May 6, 2024 (the &#147;Time of Sale&#148;), the Company will prepare certain information
(collectively, the &#147;Time of Sale Information&#148;) which information will include the Preliminary Prospectus and which will be identified in Schedule 2 hereto for such offering of Securities as constituting part of the Time of Sale
Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Purchase of the Securities by the Underwriters</U>. (a)&nbsp;The Company agrees to issue and sell the Securities to
the several Underwriters named in Schedule&nbsp;1 hereto, and each Underwriter, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees, severally and not jointly, to
purchase from the Company the respective principal amount of Securities set forth opposite such Underwriter&#146;s name in Schedule&nbsp;1 hereto at a purchase price equal to 98.926% of the principal amount of the Securities, plus accrued interest,
if any, from May&nbsp;16, 2024 to the Closing Date (as defined below), if settlement occurs after May&nbsp;16, 2024. The Company will not be obligated to deliver any of the Securities except upon payment for all the Securities to be purchased as
provided herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Payment for and delivery of the Securities shall be made at the offices of Mayer Brown LLP, Chicago, Illinois at
9:00 A.M., Chicago time, on May&nbsp;16, 2024, or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as the Representatives and the Company may agree upon in writing. The time and date of
such payment and delivery is referred to herein as the &#147;Closing Date.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Payment for the Securities shall be made by wire transfer in immediately available funds
to the account specified by the Company to the Representatives against delivery to the nominee of The Depository Trust Company, for the account of the Underwriters, of one or more global notes representing the Securities (collectively, the
&#147;Global Note&#148;), with any transfer taxes payable in connection with the sale of the Securities duly paid by the Company. The Global Note will be made available for inspection by the Representatives not later than 12:00&nbsp;P.M., Chicago
time, on the business day prior to the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company acknowledges and agrees that the Underwriters named in this
Underwriting Agreement are acting solely in the capacity of an arm&#146;s length contractual counterparty to the Company with respect to any offering of Securities contemplated hereby (including in connection with determining the terms of the
offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person. Additionally, no such Underwriter is advising the Company or any other person as to any legal, tax, investment, accounting or regulatory
matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and such Underwriters
shall have no responsibility or liability to the Company with respect thereto. Any review by such Underwriters named in this Underwriting Agreement of the Company, the transactions contemplated thereby or other matters relating to such transactions
will be performed solely for the benefit of the Underwriters and shall not be on behalf of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Representations and
Warranties of the Company</U>. The Company represents and warrants to each Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Registration Statement and
Prospectus</U>. The Registration Statement is an &#147;automatic shelf registration statement&#148; as defined under Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof, and no
notice of objection of the Commission to the use of such registration statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company. No order suspending the effectiveness of
the Registration Statement has been issued by the Commission and, to the Company&#146;s knowledge, no proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act against the Company or related to the offering has been initiated
or threatened by the Commission; as of the Effective Time, the Registration Statement complied in all material respects with the Securities Act and the Trust Indenture Act of 1939, as amended, and the rules and regulations of the Commission
thereunder (collectively, the &#147;Trust Indenture Act&#148;), and did not or will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements
therein not misleading; and as of the date of the Prospectus and any amendment or supplement thereto and as of the Closing Date, the Prospectus did not and will not contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation and warranty with respect to
(i)&nbsp;that part of the Registration Statement that constitutes the Statement of Eligibility <FONT STYLE="white-space:nowrap">(Form&nbsp;T-1)</FONT> of the Trustee under the Trust Indenture Act or (ii)&nbsp;the information contained in or omitted
from the Prospectus, or any amendment or supplement thereto, in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reliance upon and in conformity with information furnished in writing to the Company by or on behalf of the Underwriters through the Representatives specifically for inclusion therein. The
statistical and market-related data included in the Prospectus are based on or derived from sources that the Company reasonably believes to be reliable and accurate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Time of Sale Information</U>. The Time of Sale Information, at the Time of Sale and at the Closing Date did not and will not, contain
any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no
representation and warranty with respect to any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives
expressly for use in such Time of Sale Information. No statement of material fact included in the Prospectus has been omitted from the Time of Sale Information and no statement of material fact included in the Time of Sale Information that is
required to be included in the Prospectus has been omitted therefrom. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Issuer Free Writing Prospectus</U>. The Company (including
its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any &#147;written
communication&#148; (as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Securities (each such communication by the Company or its agents and representatives (other than a
communication referred to in clauses (i), (ii) and (iii)&nbsp;below) an &#147;Issuer Free Writing Prospectus&#148;) other than (i)&nbsp;any document not constituting a prospectus pursuant to Section&nbsp;2(a)(10)(a) of the Securities Act or Rule 134
under the Securities Act, (ii)&nbsp;the Preliminary Prospectus, (iii)&nbsp;the Prospectus, (iv)&nbsp;the documents listed on Schedule 2 hereto as constituting the Time of Sale Information and (v)&nbsp;any electronic road show or other written
communications, in each case approved in writing in advance by the Representatives. Each such Issuer Free Writing Prospectus complied in all material respects with the Securities Act, has been or will be (within the time period specified in Rule
433) filed in accordance with the Securities Act (to the extent required thereby) and, when taken together with the Preliminary Prospectus accompanying, or delivered prior to delivery of, or filed prior to the first use of such Issuer Free Writing
Prospectus, did not, and at the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading; <U>provided</U> that the Company makes no representation and warranty with respect to any statements or omissions made in each such Issuer Free Writing Prospectus in reliance upon and in conformity with information relating to any
Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in any Issuer Free Writing Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Incorporated Documents</U>. The documents incorporated<B> </B>by reference in the Registration Statement, the Prospectus and the Time
of Sale Information, when they were filed with the Commission, conformed in all material respects to the requirements of the Exchange Act, and any further documents so filed and incorporated or deemed to be incorporated by reference in the
Registration Statement or Prospectus, when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the documents incorporated by reference in the Registration Statement and the Prospectus, when read together with the other information in the Registration Statement and the Prospectus, at the
time filed did not, and at the Closing Date will not, contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not
misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>No Material Adverse Effect</U>. Since the respective dates as of which information is given in the Registration
Statement, the Time of Sale Information and the Prospectus, there has not been any material adverse change, or any development that would reasonably be likely to result in a material adverse change, in the general affairs, management, financial
position, stockholders&#146; equity or results of operations of the Company and its subsidiaries taken as a whole, whether or not in the ordinary course of business, in each case, otherwise than as set forth or contemplated in the Registration
Statement, the Time of Sale Information and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Organization and Good Standing</U>. The Company has been duly
incorporated and is validly existing as a corporation in good standing under the laws of the State of Delaware, with the corporate power and authority to own its properties and conduct its business as described in the Time of Sale Information and
the Prospectus; the Company is duly qualified as a foreign corporation to transact business and is in good standing in each other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the
conduct of business, except where the failure to qualify or to be in good standing would not have a material adverse effect on the general affairs, management, financial position, stockholders&#146; equity or results of operations of the Company and
its subsidiaries taken as a whole (a &#147;Material Adverse Effect&#148;); each of Canada Holding LLC, Gollek UK Limited, Keebler Company, Keebler Foods Company, Keebler Holding Corp., Kellogg Europe Company Limited, Kellogg Europe Treasury Services
Unlimited Company, Kellogg Group Limited, Kellogg Group S.&agrave;.r.l., Kellogg Holding Company Limited, Kellogg International Holding Company, Kellogg Irish Holding Limited, Kellogg Latin America Holding Company (One) Limited, Kellogg Lux III S.
&agrave;r L., Kellogg North America Company and Kellogg Sales Company (collectively, the &#147;Significant Subsidiaries&#148;) has been duly incorporated and is validly existing as a corporation in good standing under the laws of the jurisdiction of
its incorporation, with the corporate power and authority to own its properties and conduct its business as described in the Time of Sale Information and the Prospectus and is duly qualified as a foreign corporation to transact business and is in
good standing in each other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to qualify, to have been duly incorporated or to be in
existence or good standing would not have a Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Capitalization</U>. All of the issued shares of capital stock
of the Company have been duly and validly authorized and issued and are fully paid and <FONT STYLE="white-space:nowrap">non-assessable;</FONT> except as otherwise disclosed in the Registration Statement, the Time of Sale Information and the
Prospectus, all of the issued and outstanding capital stock or other ownership interests of each Significant Subsidiary have been duly authorized and validly issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and
(except for shares necessary to qualify directors or to maintain any minimum number of stockholders required by law or are immaterial to the Company&#146;s ability to control such Significant Subsidiary) are or, at the Closing Date will be, owned by
the Company, directly </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or through subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance, claim or equity except (i)&nbsp;as described in the Registration Statement, the Time of Sale
Information and the Prospectus and (ii)&nbsp;for such security interests, mortgages, pledges, liens, encumbrances, claims or equities that are immaterial to the Company and the Significant Subsidiaries taken as a whole. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Due Authorization</U>. This Underwriting Agreement has been duly authorized, executed and delivered by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>The Indenture</U>. The Indenture has been duly authorized, executed and delivered by the Company and has been duly qualified under the
Trust Indenture Act and constitutes a valid and legally binding agreement of the Company enforceable against the Company in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency or similar laws
affecting the enforcement of creditors&#146; rights generally or by equitable principles relating to enforceability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>The
Securities</U>. The Securities have been duly authorized and, when issued and authenticated in the manner provided for in the Indenture and delivered as provided herein, will have been duly executed, authenticated, issued and delivered and will
constitute valid and legally binding obligations of the Company, will be entitled to the benefits of the Indenture and will be enforceable against the Company in accordance with the terms thereof, except as enforceability may be limited by
applicable bankruptcy, insolvency or similar laws affecting the enforcement of creditors&#146; rights generally or by equitable principles relating to enforceability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <U>Descriptions of Documents</U>. The Indenture and the Securities will each conform, in all material respects, to the descriptions
thereof in the Registration Statement, the Time of Sale Information and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <U>No Violation or Default</U>. The issue and
sale of the Securities and the compliance by the Company and the Significant Subsidiaries, as applicable, with all of the provisions of the Securities, the Indenture, this Underwriting Agreement and the consummation of the transactions contemplated
herein and therein, will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or
assets of the Company or any of the Significant Subsidiaries pursuant to the terms of, any indenture, mortgage, deed of trust, loan or credit agreement or other agreement or instrument to which the Company or any of the Significant Subsidiaries is a
party or by which the Company or any of the Significant Subsidiaries is bound or to which any of the property or assets of the Company or any of the Significant Subsidiaries is subject, except where any such conflict, breach, violation, default,
creation or imposition (individually or in the aggregate) would not reasonably be expected to have a Material Adverse Effect or a material adverse effect on the ability of the Company and the Significant Subsidiaries to perform their respective
obligations hereunder; nor will such action result in any violation of the provisions of the Restated Certificate of Incorporation, as amended, or the <FONT STYLE="white-space:nowrap">By-Laws</FONT> of the Company, or the charter or bylaws of the
Significant Subsidiaries; nor will such action result in any violation of the provisions of any statute or law or any order, rule or regulation of any court or governmental agency or body having jurisdiction
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
over the Company or any of the Significant Subsidiaries or any of their properties, except where any such violation (individually or in the aggregate) would not reasonably be expected to have a
Material Adverse Effect or a material adverse effect on the ability of the Company and the Significant Subsidiaries to perform their respective obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <U>No Consents Required</U>. No consent, approval, authorization, order, registration, filing or qualification of or with any court or
governmental agency or body having jurisdiction over the Company or any of the Significant Subsidiaries or any of their properties is required for the issue and sale of the Securities or the consummation of the other transactions contemplated by the
Indenture and this Underwriting Agreement, except for such consents, approvals, authorizations, orders, registrations, filings or qualifications which shall have been obtained or made prior to the Closing Date or as may be required by the securities
or blue sky laws of the various states, the Securities Act, the Trust Indenture Act and the securities laws of any jurisdiction outside the United States in which the Securities are offered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <U>Legal Proceedings</U>. Other than as set forth in the Registration Statement, the Time of Sale Information or the Prospectus, there are
no legal or governmental proceedings pending to which the Company or any of its subsidiaries is a party or of which any property of the Company or any of its subsidiaries is the subject which would reasonably be expected to, individually or in the
aggregate, have a Material Adverse Effect or which would materially and adversely affect the consummation of the transactions contemplated under this Underwriting Agreement or the Indenture; and, to the best of the Company&#146;s knowledge, no such
proceedings are threatened or contemplated by governmental authorities or threatened by others. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <U>PricewaterhouseCoopers LLP</U>.
PricewaterhouseCoopers LLP, who have audited certain financial statements of each of the Company and its subsidiaries and delivered their reports with respect to the audited financial statements of each of the Company and its subsidiaries, is an
independent registered public accounting firm with respect to the Company within the applicable rules and regulations thereunder adopted by the Commission and the Public Company Accounting Oversight Board (United States). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) <U>Financial Statements</U>. The financial statements of the Company and its subsidiaries included or incorporated by reference in the
Registration Statement, the Time of Sale Information and Prospectus present fairly in all material respects the financial condition, results of operations and cash flows of each of the Company and its consolidated subsidiaries as of the dates and
for the periods indicated, comply in all material respects as to form with the applicable accounting requirements of the Securities Act and the Exchange Act, as applicable, and have been prepared in conformity with generally accepted accounting
principles applied on a consistent basis throughout the periods involved (except as otherwise noted therein); the selected financial data set forth under the captions &#147;Selected Consolidated Financial Data&#148; and &#147;Capitalization&#148; in
the Time of Sale Information and the Prospectus fairly present in all material respects, the information included therein. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus presents fairly the information called for in all material respects and is prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) <U>Disclosure Controls</U>. The Company maintains required &#147;disclosure controls and
procedures&#148; (as defined in Rules <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(e)</FONT> under the Exchange Act) and the Company&#146;s &#147;disclosure controls and procedures&#148; are designed
to provide reasonable assurance that<I> </I>material information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is communicated to the Company&#146;s management as appropriate to allow timely
decisions regarding required disclosure. The Company and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule <FONT STYLE="white-space:nowrap">13a-15</FONT> of the
Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) <U>Accounting Controls</U><I>.</I> The Company &#147;maintains a system of internal control over financial
reporting&#148; (as such term is defined in Rule <FONT STYLE="white-space:nowrap">13a-15(f)</FONT> of the Exchange Act) that complies with the requirements of the Exchange Act and has been designed by the Company&#146;s principal executive officer
and principal financial officer, or under their supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles; as of December&nbsp;30, 2023, the Company&#146;s internal control over financial reporting is effective and, except as otherwise disclosed in the Registration Statement, the Time of Sale Information and the Prospectus, the
Company is not aware of any changes in its internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) <U>Sarbanes-Oxley Act</U>. The Company is in compliance in all material respects with all applicable provisions of the Sarbanes-Oxley Act
of 2002 and the rules and regulations promulgated in connection therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) <U>Compliance with Environmental Laws</U>. Neither the
Company nor any of its subsidiaries is in violation of any statute, any rule, regulation, decision or order of any governmental agency or body or any court, domestic or foreign, relating to the use, disposal or release of hazardous or toxic
substances or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively, &#147;Environmental Laws&#148;), owns or operates any real property contaminated with any substance that is
subject to any environmental laws, is liable for any <FONT STYLE="white-space:nowrap">off-site</FONT> disposal or contamination pursuant to any environmental laws, or is subject to any claim relating to any environmental laws, which violation,
contamination, liability or claim would individually or in the aggregate have a Material Adverse Effect; and the Company is not aware of any pending investigation which might lead to such a claim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) <U>Title to Intellectual Property</U>. The Company and the Significant Subsidiaries own, possess, license or have other rights to use, on
reasonable terms, all patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade secrets, technology, <FONT STYLE="white-space:nowrap">know-how</FONT> and other
intellectual property (collectively, the &#147;Intellectual Property&#148;) necessary for the conduct of their respective businesses as now conducted free and clear of any material security interests, claims, liens or encumbrances, except as would
not reasonably be expected to have a Material Adverse Effect or as set forth in or contemplated in the Registration Statement, the Time of Sale Information and the Prospectus; and none of the Intellectual Property, to the knowledge of the Company,
conflicts with the valid trademark, trade name, copyright, patent, patent right or intangible asset of any other person to the extent that such conflict has or would reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) <U>Investment Company</U>. The Company is not, and upon the issuance and sale of the
Securities as herein contemplated and the application of the net proceeds therefrom as described in the Time of Sale Information and the Prospectus will not be, an &#147;investment company&#148; within the meaning of the Investment Company Act of
1940, as amended. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) <U>No Stabilization</U>. Neither the Company nor any of its affiliates nor any person acting on its or their behalf
(other than the Underwriters, as to whom the Company makes no representation) has taken, directly or indirectly, any action designed to cause or that constituted or that might reasonably be expected to cause or constitute, under the Exchange Act or
otherwise, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) <U>Forward-Looking Statements</U>. No forward-looking statement (within the meaning of Section&nbsp;27A of the Securities Act and
Section&nbsp;21E of the Exchange Act) contained or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in
good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) <U>Status Under the Securities Act.</U> The Company was a &#147;well-known seasoned issuer&#148; as defined in Rule 405
under the Securities Act (A)&nbsp;at the time of filing the Registration Statement, (B)&nbsp;at the time of the most recent amendment to the Registration Statement for the purpose of complying with Section&nbsp;10(a)(3) of the Securities Act
(whether such amendment was by post-effective amendment, incorporated report filed pursuant to Section&nbsp;13 or 15(d) of the Exchange Act or form of prospectus filed pursuant to the Securities Act), and (C)&nbsp;at the time the Company or any
person acting on its behalf (within the meaning, for this clause only, of Rule 163(c) under the Securities Act) made any offer relating to the Securities in reliance on the exemption of Rule 163 under the Securities Act; and the Company was not an
&#147;ineligible issuer&#148; as defined in Rule 405 under the Securities Act at the earliest time after the filing of the Registration Statement that the Company or any Underwriter made a bona fide offer (within the meaning of Rule 164(h)(2) under
the Securities Act) of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Further Agreements of the Company</U>. The Company covenants and agrees with each
Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Filings with the Commission</U>. The Company will file the Prospectus in a form approved by the Underwriters with
the Commission pursuant to Rule&nbsp;424 under the Securities Act not later than the close of business on the second business day following the date of determination of the public offering price of the Securities or, if applicable, such earlier time
as may be required by Rule&nbsp;424(b) and Rule&nbsp;430A, 430B or 430C under the Securities Act. The Company will file any Issuer Free Writing Prospectus (including the Term Sheet in the form of Schedule 3 to this Underwriting Agreement) to the
extent required by Rule 433 under the Securities Act; and the Company will furnish copies of the Prospectus to the Underwriters in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
New York City prior to 10:00&nbsp;A.M., New York City time, on the second day succeeding the date of this Underwriting Agreement in such quantities as the Representatives may reasonably request.
If at any time when Securities remain unsold by the Underwriters the Company receives from the Commission a notice pursuant to Rule 401(g)(2) or otherwise ceases to be eligible to use the automatic shelf registration statement form, the Company will
(i)&nbsp;promptly notify the Underwriters and (ii)&nbsp;subject to paragraph (d), promptly take such action as shall be necessary to permit the public offering and sale of the Securities to continue as soon as practicable after receipt of such
notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Filing Fees</U>. The Company agrees to pay the required Commission filing fees relating to the Securities within the time
required by Rule&nbsp;456(b)(1) of the Securities Act without regard to the proviso therein and otherwise in accordance with Rules&nbsp;456(b) and 457(r) of the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Delivery of Copies</U>. The Company will deliver, without charge, to each Underwriter during the Prospectus Delivery Period (as defined
below), as many copies of the Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein) and each Issuer Free Writing Prospectus (if applicable) as the Representatives may reasonably request. As
used herein, the term &#147;Prospectus Delivery Period&#148; means such period of time after the first date of the public offering of the Securities as in the opinion of counsel for the Underwriters a prospectus relating to the Securities is
required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Securities by any Underwriter or dealer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Amendments or Supplements; Issuer Free Writing Prospectuses</U>. Before making, preparing, using, authorizing, approving, referring to
or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement or the Prospectus, the Company will furnish to the Representatives and counsel for the Underwriters a copy of the proposed
Issuer Free Writing Prospectus, amendment or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed amendment or supplement to which the
Representatives reasonably object. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Notice to the Representatives</U><I>.</I> The Company will advise the Representatives promptly,
and confirm such advice in writing, (i)&nbsp;when any amendment to the Registration Statement has been filed or becomes effective; (ii)&nbsp;when any supplement to the Prospectus or any amendment to the Prospectus or any Issuer Free Writing
Prospectus has been filed; (iii)&nbsp;of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt of any comments from the Commission relating to the Registration
Statement or any other request by the Commission for any additional information; (iv)&nbsp;of the issuance by the Commission of any order suspending the effectiveness of the Registration Statement or preventing or suspending the use of any
Preliminary Prospectus or the Prospectus or the initiation or threatening of any proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act; (v)&nbsp;of the occurrence of any event within the Prospectus Delivery Period as a
result of which the Prospectus, the Time of Sale Information or any Issuer Free Writing Prospectus as then amended or supplemented would include any untrue statement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances existing when the
Prospectus, the Time of Sale Information or any Issuer Free Writing Prospectus is delivered to a purchaser, not misleading; and (vi)&nbsp;of the receipt by the Company of any notice with respect to any suspension of the qualification of the
Securities for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the issuance of any such order suspending the effectiveness of the
Registration Statement, preventing or suspending the use of any Preliminary Prospectus or the Prospectus or suspending any such qualification of the Securities and, if any such order is issued, will obtain as soon as possible the withdrawal thereof.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Time of Sale Information</U><I>.</I> If at any time prior to the Closing Date (i)&nbsp;any event shall occur or condition shall
exist as a result of which the Time of Sale Information as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the
circumstances, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Time of Sale Information to comply with law, the Company will immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph
(d)&nbsp;above, file with the Commission (to the extent required) and furnish to the Underwriters and to such dealers as the Representatives may designate, such amendments or supplements to the Time of Sale Information as may be necessary so that
the statements in the Time of Sale Information as so amended or supplemented will not, in the light of the circumstances, be misleading or so that the Time of Sale Information will comply with law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Ongoing Compliance</U><I>. </I>If during the Prospectus Delivery Period (i)&nbsp;any event shall occur or condition shall exist as a
result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in the light
of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Prospectus to comply with law, the Company will immediately notify the Underwriters thereof and
forthwith prepare and, subject to paragraph (d)&nbsp;above, file with the Commission and furnish to the Underwriters and to such dealers as the Representatives may designate, such amendments or supplements to the Prospectus as may be necessary so
that the statements in the Prospectus as so amended or supplemented will not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that the Prospectus will comply with law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Blue Sky Compliance</U>. The Company will arrange, if necessary, for the qualification of the Securities for sale by the Underwriters
under the laws of such jurisdictions as the Representatives may reasonably designate and will maintain such qualifications in effect so long as required for the sale of the Securities; <U>provided</U> that in no event shall the Company be obligated
to qualify to do business in any jurisdiction where it is not now so qualified or to take any action that would subject it to service of process in suits in any jurisdiction where it is not now so subject or subject themselves to taxation in any
such jurisdiction where it is not then so subject. The Company will promptly advise the Representatives of the receipt by the Company of any notification with respect to the suspension of the qualification of the Securities for sale in any
jurisdiction or the initiation or threatening of any proceeding for such purpose. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Book-Entry</U>. The Company will cooperate with the Underwriters and use its
reasonable best efforts to permit the Securities to be eligible for clearance and settlement through The Depository Trust Company, Clearstream Banking S.A. (&#147;Clearstream&#148;) and Euroclear Bank SA/NV (&#147;Euroclear&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>Clear Market</U>. The Company will not during the period from the date hereof through and including the Closing Date, without the prior
written consent of the Representatives, offer, sell, contract to sell, grant any other option to purchase or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition
(whether by actual disposition or effective economic disposition due to cash settlement or otherwise) by the Company or any affiliate of the Company or any person in privity with the Company or any affiliate of the Company), directly or indirectly,
or announce the offering of, any debt securities issued or guaranteed by the Company (other than the Securities, up to &#128;300,000,000 aggregate principal amount of debt securities and commercial paper). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <U>No Stabilization</U>. The Company will not take, directly or indirectly, any action designed to or that would constitute or that might
reasonably be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <U>Use of Proceeds</U>. The Company will use the net proceeds received by it from the sale of the Securities in the manner specified in
the Time of Sale Information and the Prospectus under the caption &#147;Use of Proceeds.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <U>Earning Statement</U><I>.</I> The
Company will make generally available to its security holders as soon as practicable an earning statement that satisfies the provisions of Section&nbsp;11(a) of the Securities Act and Rule&nbsp;158 of the Commission promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <U>Filing of Exchange Act Documents</U><I>.</I> The Company will file promptly all reports and any definitive proxy or information
statements required to be filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act during the Prospectus Delivery Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <U>Record Retention</U>. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free
Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Certain Agreements
of the Underwriters</U>. Each Underwriter hereby makes the representations and warranties set forth in Annex A hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Conditions of Underwriters&#146; Obligations</U>. The obligation of each Underwriter
to purchase Securities on the Closing Date as provided herein is subject to the performance by the Company of its covenants and other obligations hereunder and to the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Registration Compliance; No Stop Order</U><I>.</I> No order suspending the effectiveness of the Registration Statement shall be in
effect, and no proceeding for such purpose or pursuant to Section&nbsp;8A under the Securities Act shall be pending before or threatened by the Commission, and no notice of objection of the Commission to use the Registration Statement or any
post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act shall have been received; the Prospectus and each Issuer Free Writing Prospectus shall have been timely filed with the Commission under the Securities Act and in
accordance with Section&nbsp;4(a) hereof; and all requests by the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Representations and Warranties</U><I>.</I> The representations and warranties of the Company contained herein shall be true and correct
in all material respects on the date hereof and on and as of the Closing Date; and the statements of the Company and its officers made in any certificates delivered pursuant to this Underwriting Agreement shall be true and correct in all material
respects on and as of the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>No Downgrade</U><I>.</I> Subsequent to the earlier of (A)&nbsp;the Time of Sale and
(B)&nbsp;the execution and delivery of this Underwriting Agreement, and prior to the Closing Date, there shall not have been any decrease in the rating of any of the Company&#146;s debt securities by any &#147;nationally recognized statistical
rating organization&#148; (as defined in Section&nbsp;3(a)(62) of the Exchange Act) and no such organization shall have publicly announced that it has under surveillance or review (other than an announcement with positive implications of a possible
upgrade), its rating of the Company&#146;s debt securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>No Material Adverse Effect</U><I>.</I> Subsequent to the execution and
delivery of this Underwriting Agreement, or, if earlier, the date of the latest financial statements included in the Time of Sale Information and the Prospectus, there has not been any change, or any development involving a prospective change, in or
affecting the condition (financial or otherwise), prospects, earnings, business or properties of the Company and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth or
contemplated in the Time of Sale Information (excluding any amendment or supplement thereto) and the Prospectus, the effect of which is, in the judgment of the Representatives, so material and adverse as to make it impracticable or inadvisable to
market the Securities as contemplated by this Underwriting Agreement, the Time of Sale Information and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)
<U>Officer&#146;s Certificate</U><I>.</I> The Representatives shall have received on and as of the Closing Date a certificate of an executive officer of the Company who has specific knowledge of the Company&#146;s financial matters and is
satisfactory to the Representatives confirming that such officer has carefully reviewed the Registration Statement, the Time of Sale Information and the Prospectus and, to the best knowledge of such officer, (i)&nbsp;the representations set forth in
Sections&nbsp;3(a) and 3(b) hereof are true and correct, (ii)&nbsp;the other representations and warranties of the Company in this Underwriting Agreement are true and correct and that the Company has complied with all agreements and satisfied all
conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date and (iii)&nbsp;to the effect set forth in paragraphs (a), (c)&nbsp;and (d)&nbsp;above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Comfort Letters</U><I>.</I> On the date of this Underwriting Agreement and on the
Closing Date, PricewaterhouseCoopers LLP shall have furnished to the Representatives, at the request of the Company, letters, dated the respective dates of delivery thereof and addressed to the Underwriters, in form and substance reasonably
satisfactory to the Representatives containing statements and information of the type customarily included in accountants&#146; &#147;comfort letters&#148; to underwriters with respect to the financial statements and certain financial information
contained or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus; <U>provided</U> that the letter delivered on the Closing Date shall use a
<FONT STYLE="white-space:nowrap">&#147;cut-off&#148;</FONT> date no more than three business days prior to the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)
<U>Opinion of <FONT STYLE="white-space:nowrap">In-House</FONT> Counsel for the Company</U><I>.</I> John Min, Senior Vice President, Chief Legal Officer and Secretary of the Company, shall have furnished to the Representatives, at the request of the
Company, his written opinion, dated the Closing Date and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, to the effect set forth in Annex B hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Opinion of Counsel for the Company</U><I>.</I> Kirkland&nbsp;&amp; Ellis LLP, counsel for the Company, shall have furnished to the
Representatives, at the request of the Company, their written opinion, dated the Closing Date and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, to the effect set forth in Annex C hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Opinion of Counsel for the Underwriters</U><I>.</I> The Representatives shall have received on and as of the Closing Date an opinion of
Mayer Brown LLP, counsel for the Underwriters, with respect to such matters as the Representatives may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon
such matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>No Legal Impediment to Issuance</U><I>.</I> No action shall have been taken and no statute, rule, regulation or
order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Securities; and no injunction or order of any federal,
state or foreign court shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)
<U>Clearance</U>. The Securities shall be eligible for clearance and settlement through The Depository Trust Company, Clearstream and Euroclear. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <U>Additional Documents</U><I>.</I> On or prior to the Closing Date, the Company shall have furnished to the Representatives such further
certificates and documents as the Representatives may reasonably request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All opinions, letters, certificates and evidence mentioned
above or elsewhere in this Underwriting Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Indemnification and Contribution</U>. <B></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Indemnification of the Underwriters</U><I>.</I> The Company agrees to indemnify and hold harmless each Underwriter, its affiliates,
directors and officers and each person, if any, who controls such Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities
(including, without limitation, reasonable legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted as such fees and expenses are incurred), joint or several, that (i)&nbsp;arise out of, or are
based upon, any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, or are caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in
order to make the statements therein, not misleading, or (ii)&nbsp;arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Issuer
Free Writing Prospectus or any Time of Sale Information, or are caused by any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made,
not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any
information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Indemnification of the Company</U><I>.</I> Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the
Company, its directors, its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act to the same extent as the
indemnity set forth in paragraph (a)&nbsp;above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon
and in conformity with any information relating to such Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the Registration Statement, the Prospectus (or any amendment or supplement
thereto) any Issuer Free Writing Prospectus or any Time of Sale Information, it being understood and agreed that the only such information consists of the information in the last paragraph on the cover page of the Prospectus, the information in the
table on Page S-25 listing the &#147;Underwriters&#148; and &#147;Principal Amount of Notes&#148; and the information in the third and sixth paragraphs and the fourth sentence of the seventh paragraph under the caption &#147;Underwriting (Conflicts
of Interest)&#148; beginning on page S-25 of the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Notice and Procedures</U><I>.</I> If any suit, action, proceeding
(including any governmental or regulatory investigation), claim or demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to either paragraph (a)&nbsp;or (b)&nbsp;above, such person (the
&#147;Indemnified Person&#148;) shall promptly notify the person against whom such indemnification may be sought (the &#147;Indemnifying Person&#148;) in writing; <U>provided</U> that the failure to notify the Indemnifying Person shall not relieve
it from any liability that it may have under this Section&nbsp;7 except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and <U>provided</U>, <U>further</U>, that the
failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person otherwise than under this Section&nbsp;7. If any such proceeding shall be brought
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified
Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified Person and any others entitled to indemnification pursuant to this Section&nbsp;7 that the Indemnifying Person
may designate in such proceeding and shall pay the reasonable fees and expenses of such proceeding and shall pay the fees and expenses of counsel related to such proceeding as incurred. In any such proceeding, any Indemnified Person shall have the
right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i)&nbsp;the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary;
(ii)&nbsp;the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii)&nbsp;the Indemnified Person shall have reasonably concluded that there may be legal defenses available
to it that are different from or in addition to those available to the Indemnifying Person; or (iv)&nbsp;the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and
representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related
proceeding in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be reimbursed as they are incurred. Any
such separate firm for any Underwriter, its affiliates, directors and officers and any control persons of such Underwriter shall be designated in writing by the Representatives and any such separate firm for the Company, its directors, its officers
who signed the Registration Statement and any control persons of the Company shall be designated in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without its written consent, but if
settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement or judgment. Notwithstanding the
foregoing sentence, if at any time an Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified Person for reasonable fees and expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall
be liable for any settlement of any proceeding effected without its written consent if (i)&nbsp;such settlement is entered into more than 60&nbsp;days after receipt by the Indemnifying Person of such request and (ii)&nbsp;the Indemnifying Person
shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of any pending or
threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x)&nbsp;includes an unconditional release of such
Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y)&nbsp;does not include any statement as to or any admission of fault,
culpability or a failure to act by or on behalf of any Indemnified Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Contribution</U><I>.</I> If the indemnification provided for in paragraphs
(a)&nbsp;and (b)&nbsp;above is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such
Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits
received by the Company on the one hand and the Underwriters on the other from the offering of the Securities or (ii)&nbsp;if the allocation provided by clause (i)&nbsp;is not permitted by applicable law, in such proportion as is appropriate to
reflect not only the relative benefits referred to in clause (i)&nbsp;but also the relative fault of the Company on the one hand and the Underwriters on the other in connection with the statements or omissions that resulted in such losses, claims,
damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Underwriters on the other shall be deemed to be in the same respective proportions as the net
proceeds (before deducting expenses) received by the Company from the sale of the Securities and the total underwriting discounts and commissions received by the Underwriters in connection therewith, in each case as set forth in the table on the
cover of the Prospectus, bear to the aggregate offering price of the Securities. The relative fault of the Company on the one hand and the Underwriters on the other shall be determined by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters and the parties&#146; relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Limitation on Liability</U><I>.</I> The Company and the
Underwriters agree that it would not be just and equitable if contribution pursuant to this Section&nbsp;7 were determined by <U>pro</U> <U>rata</U> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other
method of allocation that does not take account of the equitable considerations referred to in paragraph (d)&nbsp;above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in
paragraph (d)&nbsp;above shall be deemed to include, subject to the limitations set forth above, any reasonable legal or other expenses incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions
of this Section&nbsp;7, in no event shall an Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the
Securities exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the
meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters&#146; obligations to contribute pursuant to this Section&nbsp;7 are
several in proportion to their respective purchase obligations hereunder and not joint. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)
<U><FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Remedies</U><I>.</I> The remedies provided for in this Section&nbsp;7 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Person at
law or in equity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Termination</U>. This Underwriting Agreement may be terminated in the absolute discretion of the Representatives,
by notice to the Company, if after the execution and delivery of this Underwriting Agreement and prior to the Closing Date (i)&nbsp;trading generally shall have been suspended or materially limited on the New York Stock Exchange or the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
market; (ii)&nbsp;trading of any securities issued or guaranteed by the Company shall have been suspended on any exchange or in any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or minimum prices shall have been established on the New York Stock Exchange or in any <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (iii)&nbsp;a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities or by European Union authorities; or (iv)&nbsp;there
shall have occurred any outbreak or escalation of hostilities, declaration by the United States or a member of the European Union of a national emergency or war or any change in financial markets or any calamity or crisis, either within or outside
the United States, that, in the judgment of the Representatives, is so material and adverse as to make it, in the judgment of the Representatives, impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the
terms and in the manner contemplated by this Underwriting Agreement, the Time of Sale Information and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Defaulting
Underwriter</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) If, on the Closing Date, any Underwriter defaults on its obligation to purchase the Securities that it has agreed to
purchase hereunder, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters may in their discretion arrange for the purchase of such Securities by other persons satisfactory to the Company on the terms contained in this Underwriting
Agreement. If, within 36 hours after any such default by any Underwriter, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters do not arrange for the purchase of such Securities, then the Company shall be entitled to a further
period of 36 hours within which to procure other persons satisfactory to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters to purchase such Securities on such terms. If other persons become obligated or agree to purchase the
Securities of a defaulting Underwriter, either the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or the Company may postpone the Closing Date for up to five full business days in order to effect any changes that in the opinion
of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any amendment or supplement to the
Registration Statement and the Prospectus that effects any such changes. As used in this Underwriting Agreement, the term &#147;Underwriter&#148; includes, for all purposes of this Underwriting Agreement unless the context otherwise requires, any
person not listed in this Underwriting Agreement that, pursuant to this Section&nbsp;9, purchases Securities that a defaulting Underwriter agreed but failed to purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains unpurchased does not exceed
<FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate principal amount of all the Securities, then the Company shall have the right to require each <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter to purchase the
principal amount of Securities that such Underwriter agreed to purchase hereunder plus such Underwriter&#146;s <U>pro</U> <U>rata</U> share (based on the principal amount of Securities that such Underwriter agreed to purchase hereunder) of the
Securities of such defaulting Underwriter or Underwriters for which such arrangements have not been made. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains unpurchased
exceeds <FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate principal amount of all the Securities, or if the Company shall not exercise the right described in paragraph (b)&nbsp;above, then this Underwriting Agreement shall
terminate without liability on the part of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters. Any termination of this Underwriting Agreement pursuant to this Section&nbsp;9 shall be without liability on the part of the Company,
except that the Company will continue to be liable for the payment of expenses as set forth in Section&nbsp;10 hereof and except that the provisions of Section&nbsp;7 hereof shall not terminate and shall remain in effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter for damages caused by its default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Payment of Expenses</U><I>.</I>
(a)&nbsp;Whether or not the transactions contemplated by this Underwriting Agreement are consummated or this Underwriting Agreement is terminated, the Company will pay or cause to be paid all costs and expenses incident to the performance of its
obligations hereunder, including without limitation, (i)&nbsp;the copying and distribution of the Indenture and the preparation of the certificates representing the Securities; (ii)&nbsp;the costs incident to the preparation, printing and filing
under the Securities Act of the Registration Statement, any Preliminary Prospectus and the Prospectus (including all exhibits, amendments and supplements thereto) and the distribution thereof; (iii)&nbsp;the printing (or reproduction) and delivery
(including postage, air freight charges and charges for counting and packaging) of such copies of any Preliminary Prospectus Supplement, any Issuer Free Writing Prospectus, any Time of Sale Information and the Prospectus, and all amendments or
supplements to either of them, as may, in each case, be reasonably requested for use in connection with the offering and sale of the Securities; (iv)&nbsp;the preparation, printing, authentication, issuance and delivery of certificates for the
Securities, including any stamp or transfer taxes in connection with the original issuance and sale of the Securities; (v)&nbsp;the printing (or reproduction) and delivery of this Underwriting Agreement and all other agreements or documents printed
(or reproduced) and delivered in connection with the offering of the Securities; (vi)&nbsp;the fees and expenses incurred in connection with the registration or qualification and determination of eligibility for investment of the Securities under
the securities or blue sky laws of such jurisdictions as the Representatives may designate (including filing fees) and the preparation, printing and distribution of a Blue Sky Memorandum (including the related reasonable fees and expenses of counsel
for the Underwriters); (vii) the transportation and other expenses incurred by or on behalf of Company representatives in connection with presentations to prospective purchasers of the Securities; (viii)&nbsp;the fees and expenses of the
Company&#146;s accountants and the fees and expenses of counsel (including local and special counsel) for the Company; (ix)&nbsp;any fees charged by securities rating services for rating the Securities; (x)&nbsp;the fees and expenses of the Trustee
and any agent of the Trustee, including any paying agent, and the fees and disbursements of counsel for the Trustee in connection with the Indenture and the Securities; (xi)&nbsp;all expenses and application fees incurred in connection with any
filing with, and clearance of any offering by the Financial Industry Regulatory Authority, Inc.; and (xii)&nbsp;all other costs and expenses incurred by the Company incident to the performance by the Company of its obligations hereunder. It is
understood, however, that except as provided in this Section&nbsp;10 and Section&nbsp;7, the Underwriters shall pay their own expenses on a pro rata basis in accordance with the amount of Securities purchased by such Underwriter as set forth on
<U>Schedule 1</U>, including the fees and disbursements of their counsel. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If (i)&nbsp;this Underwriting Agreement is terminated pursuant to Section&nbsp;8,
(ii)&nbsp;the Company for any reason fails to tender the Securities for delivery to the Underwriters or (iii)&nbsp;the Underwriters decline to purchase the Securities for any reason permitted under this Underwriting Agreement, the Company agrees to
reimburse the Underwriters for all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses (including the fees and expenses of their counsel) reasonably incurred by the Underwriters in
connection with this Underwriting Agreement and the offering contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Persons Entitled to Benefit of Agreement</U>.
This Underwriting Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each Underwriter
referred to in Section&nbsp;7 hereof. Nothing in this Underwriting Agreement is intended or shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Underwriting Agreement or any provision
contained herein. No purchaser of Securities from any Underwriter shall be deemed to be a successor merely by reason of such purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Survival</U>. The respective indemnities, rights of contribution, representations, warranties and agreements of the Company and the
Underwriters contained in this Underwriting Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Underwriting Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment for the
Securities and shall remain in full force and effect, regardless of any termination of this Underwriting Agreement or any investigation made by or on behalf of the Company or the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Information Provided by Underwriters</U>. At Closing, the Underwriters will deliver a letter to the Company acknowledging the only
information relating to any Underwriter that has been furnished to the Company in writing by any Underwriter through the Representatives expressly for use in the Registration Statement and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Certain Defined Terms</U>. For purposes of this Underwriting Agreement, (a)&nbsp;except where otherwise expressly provided, the term
&#147;affiliate&#148; has the meaning set forth in Rule&nbsp;405 under the Securities Act; (b)&nbsp;the term &#147;business day&#148; means any day other than a day on which banks are permitted or required to be closed in New York City and
(c)&nbsp;the term &#147;subsidiary&#148; has the meaning set forth in Rule&nbsp;405 under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Miscellaneous</U>.
(a)<U>&nbsp;Authority of the Representatives</U><I>. </I>Any action by the Underwriters hereunder may be taken by the Representatives on behalf of the Underwriters, and any such action taken by the Representatives shall be binding upon the
Underwriters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Notices</U><I>.</I> All notices and other communications hereunder shall be in
writing and shall be deemed to have been duly given if mailed or transmitted and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to the Representatives at Citigroup Global Markets Inc., 388 Greenwich
Street, New York, New York 10013, Attention: General Counsel (fax no. (646) <FONT STYLE="white-space:nowrap">291-1469);</FONT> J.P. Morgan Securities LLC, 383 Madison Avenue New York, New York 10179, Attention: Investment Grade Syndicate Desk (fax
no. (212) <FONT STYLE="white-space:nowrap">834-6081);</FONT> Morgan Stanley&nbsp;&amp; Co. LLC, 1585 Broadway, New York, New York 10036, Attention: Equity Syndicate Desk with a copy to the Legal Department (fax no. (212) <FONT
STYLE="white-space:nowrap">507-8999).</FONT> Notices to the Company shall be given to it at 412 N. Wells Street, Chicago, Illinois 60654 (fax no: (269) <FONT STYLE="white-space:nowrap">565-1266);</FONT> Attention: General Counsel, or if different,
to the address set forth in this Underwriting Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Governing Law</U><I>.</I> This Underwriting Agreement shall be governed
by and construed in accordance with the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Amendments or Waivers</U><I>.</I> No amendment or waiver of
any provision of this Underwriting Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Headings</U><I>.</I> The headings herein are included for convenience of reference only and are not intended to be part of, or to
affect the meaning or interpretation of, this Underwriting Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Counterparts</U>. This Underwriting Agreement may be signed
in counterparts (which may include counterparts delivered by any standard form of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Recognition of the U.S. Special Resolution Regimes.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the
transfer from such Underwriter of this Underwriting Agreement, and any interest and obligation in or under this Underwriting Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime
if this Underwriting Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding
under a U.S. Special Resolution Regime, Default Rights under this Underwriting Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S.
Special Resolution Regime if this Underwriting Agreement were governed by the laws of the United States or a state of the United States. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As used in this Section&nbsp;16: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;BHC Act Affiliate&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in accordance with, 12
U.S.C. &#167; 1841(k). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;Covered Entity&#148; means any of the following: (i)&nbsp;a &#147;covered entity&#148;
as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); (ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or (iii)&nbsp;a &#147;covered
FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;Default Right&#148; has the
meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;U.S. Special Resolution Regime&#148; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder
and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Remainder of Page Intentionally Left Blank] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding, please indicate your acceptance
of this Underwriting Agreement by signing in the space provided below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">KELLANOVA</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Joel A. Vanderkooi</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Joel A. Vanderkooi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Vice President and Treasurer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accepted: May&nbsp;6, 2024 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Underwriting Agreement]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Accepted: May&nbsp;6, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CITIGROUP GLOBAL MARKETS INC.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. MORGAN SECURITIES LLC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">MORGAN STANLEY&nbsp;&amp; CO. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: CITIGROUP GLOBAL MARKETS INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam D. Bordner</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Adam D. Bordner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: J.P. MORGAN SECURITIES LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Robert Bottamedi</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Robert Bottamedi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Executive Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By: MORGAN STANLEY&nbsp;&amp; CO. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Julie Blanco</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Julie Blanco</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Executive Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For themselves and on behalf of the several</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Underwriters listed in Schedule 1 hereto.</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Underwriting Agreement]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule&nbsp;1 </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal<BR>Amount</B><br><B>of&nbsp;the&nbsp;2054&nbsp;Notes</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 78,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">78,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SMBC Nikko Securities America, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TD Securities (USA) LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Bancorp Investments, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scotia Capital (USA) Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SG Americas Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Blaylock Van, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R. Seelaus&nbsp;&amp; Co., LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">300,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 2 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Time of Sale Information </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The term sheet set forth in Schedule 3 hereto. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 3 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Free Writing Prospectus </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 433 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration No.&nbsp;333-279131 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Relating to the Preliminary Prospectus Supplement dated May&nbsp;6, 2024 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>(to Prospectus dated May&nbsp;6, 2024) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$300,000,000 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Kellanova
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5.750% Senior Notes due 2054 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Pricing Term Sheet </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">May&nbsp;6,
2024 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Issuer:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Kellanova</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ratings (Moody&#146;s/Fitch):*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[Intentionally Omitted]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trade Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">May&nbsp;6, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Settlement Date:**</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">May&nbsp;16, 2024 (T+8)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Joint Book-Running Managers:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan
Securities LLC</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Co-Managers:</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SMBC Nikko Securities
America, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TD Securities (USA) LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">U.S. Bancorp
Investments, Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Scotia Capital (USA) Inc.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SG Americas
Securities, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Blaylock Van, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">R. Seelaus&nbsp;&amp; Co.,
LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Principal Amount:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$300,000,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Maturity Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">May&nbsp;16, 2054</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Interest Payment Dates:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">May&nbsp;16 and November&nbsp;16, beginning November&nbsp;16, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Benchmark Treasury:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">UST 4.750% due November&nbsp;15, 2053</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Benchmark Treasury Price and Yield:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">101-25</FONT> / 4.639%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Spread to Benchmark Treasury:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">+112.5 bps</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Yield to Maturity:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.764%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Coupon (Interest Rate):</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.750%</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Price to Public:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">99.801%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Optional Redemption:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to November&nbsp;16, 2053 (the date that is six months prior to the maturity date of the notes) (the &#147;Par Call Date&#148;), the
Issuer may redeem the Notes at its option, at any time in whole or from time to time in part, at a redemption price (expressed as a percentage of the principal amount and rounded to three decimal places) equal to the greater of:</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;100% of the principal amount
of the Notes being redeemed; and</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;(a) the sum of the present values of the remaining scheduled payments of principal and interest
thereon discounted to the redemption date (assuming the Notes matured on the Par Call Date) on a semi-annual basis (assuming a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT>
months) at the Treasury Rate plus 20 basis points less (b)&nbsp;interest accrued to the date of redemption.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Issuer will also pay accrued and unpaid interest, if any, on the Notes to the redemption date.</P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">On and after the Par Call Date, the Issuer may redeem the Notes at its option, at any
time in whole or from time to time in part, at a redemption price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest, if any, on the Notes to the redemption date.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CUSIP / ISIN:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">487836 CA4 / US487836CA47</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>*</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Note: </B>A securities rating is not a recommendation to buy, sell or hold securities and may be subject to
revision or withdrawal at any time. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">It is expected that delivery of the notes will be made against payment therefore on or about May&nbsp;16, 2024,
which is the eighth business day following the date hereof (such settlement cycle being referred to as &#147;T+8&#148;). Under Rule <FONT STYLE="white-space:nowrap">15c6-1</FONT> under the Securities Exchange Act of 1934, as amended, trades in the
secondary market generally are required to settle in two business days unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the notes prior to the second business day before the delivery of the
notes will be required, by virtue of the fact that the notes initially will settle in T+8, to specify an alternative settlement cycle at the time of any such trade to prevent failed settlement. Purchasers of the notes who wish to trade the notes on
the date of pricing should consult their own advisors. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The issuer has filed a registration statement (including a prospectus) with
the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and
this offering. You may get these documents for free by visiting EDGAR on the SEC web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request
it by calling Citigroup Global Markets Inc. toll-free at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-831-9146,</FONT></FONT></FONT> J.P. Morgan Securities LLC (collect) at <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-834-4533</FONT></FONT> or Morgan Stanley&nbsp;&amp; Co. LLC at
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-866-718-1649.</FONT></FONT></FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Any
disclaimers or other notices that may appear below are not applicable to this communication and should be disregarded. Such disclaimers were automatically generated as a result of this communication being sent via Bloomberg or another email system.
</B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><U>Annex A </U></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Underwriters&#146; Representations and Warranties </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) It has not and will not use, authorize use of, refer to, or participate in the planning for use of, any &#147;free writing
prospectus,&#148; as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company and not incorporated by reference into the Registration Statement and any press release
issued by the Company) other than (i)&nbsp;a free writing prospectus that, solely as a result of use by such Underwriter, would not trigger an obligation to file such free writing prospectus with the Commission or is not required to be retained by
the Company pursuant to Rule 433, (ii) any Issuer Free Writing Prospectus listed on Schedule 3 or prepared pursuant to Section&nbsp;3(c) or Section&nbsp;4(d) above (including any electronic road show), or (iii)&nbsp;any free writing prospectus
prepared by such underwriter and approved by the Company in advance in writing (each such free writing prospectus referred to in clauses (i)&nbsp;or (iii), an &#147;Underwriter Free Writing Prospectus&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It has not used and will not, without the prior written consent of the Company, use any free writing prospectus that contains the final
terms of the Securities unless such terms have previously been included in a free writing prospectus filed with the Commission; provided that the Underwriters may, at any time, use a term sheet substantially in the form of Schedule 3 hereto without
the consent of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) It is not subject to any pending proceeding under Section&nbsp;8A of the Securities Act with respect to
the offering (and will promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) It has represented and agreed that it has not offered, sold or otherwise made available and will not offer, sell or otherwise make
available the Securities to any retail investor in the European Economic Area or in the United Kingdom. For the purposes of this provision: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the expression &#147;retail investor&#148; means a person who is one (or more) of the following: (a)&nbsp;a
retail client as defined in point (11)&nbsp;of Article 4(1) of Directive 2014/65/EU (as amended, &#147;MiFID II&#148;), or (b)&nbsp;a customer within the meaning of Directive (EU) 2016/97 (as amended), where that customer would not qualify as a
professional client as defined in point (10)&nbsp;of Article 4(1) of MiFID II or (c)&nbsp;not a qualified investor as defined in Regulation (EU) 2017/1129; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the expression &#147;offer&#148; includes the communication in any form and by any means of sufficient
information on the terms of the offer and the Securities to be offered so as to enable an investor to decide to purchase or subscribe the Securities. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;(i) it has only communicated or caused to be communicated and will only communicate
or cause to be communicated any invitation or inducement to engage in investment activity (within the meaning of Section&nbsp;21 of the Financial Services and Markets Act 2000, as amended (&#147;FSMA&#148;)) received by it in connection with the
issue or sale of the Securities in circumstances in which Section&nbsp;21(1) of the FSMA does not apply to the Company; and (ii)&nbsp;it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in
relation to the Securities in, from or otherwise involving the United Kingdom. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><U>Annex B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Provided under separate cover</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><U>Annex C </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Provided under separate cover</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex C-1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.2
<SEQUENCE>3
<FILENAME>d804742dex12.htm
<DESCRIPTION>EX-1.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.2 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Execution Version </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&#128;300,000,000 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>KELLANOVA </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>3.750% Senior
Notes due 2034 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Underwriting Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May&nbsp;7, 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Bank PLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Merrill Lynch International </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Co&ouml;peratieve Rabobank U.A. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As representatives of the Several Underwriters </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Barclays Bank PLC </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">1 Churchill Place </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">London, E14
5HP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">United Kingdom </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Merrill
Lynch International </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">2 King Edward St </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">London EC1A 1HQ </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">United Kingdom
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Co&ouml;peratieve Rabobank U.A. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Croeselaan 18 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">3521 CB Utrecht
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Netherlands </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Kellanova, a Delaware corporation (the &#147;Company&#148;), proposes to issue and sell to the several Underwriters listed in Schedule&nbsp;1
hereto (the &#147;Underwriters&#148;), for whom you are acting as representatives (the &#147;Representatives&#148;), &#128;300,000,000 aggregate principal amount of its 3.750% Senior Notes due 2034 (the &#147;Securities&#148;). The Securities will
be issued pursuant to an Indenture, dated as of May&nbsp;6, 2024 (the &#147;Indenture&#148;), between the Company and U.S. Bank Trust Company, National Association, as trustee (the &#147;Trustee&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Registration Statement</U>. The Company has prepared and filed with the Securities and Exchange Commission (the &#147;Commission&#148;)
under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#147;Securities Act&#148;), a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3</FONT> (File <FONT
STYLE="white-space:nowrap">No.&nbsp;333-279131),</FONT> including a prospectus (the &#147;Basic Prospectus&#148;), relating to the debt securities to be issued from time to time by the Company. The Registration Statement (as defined below) is an
&#147;automatic shelf registration statement,&#148; as defined in Rule 405 of the Act, that automatically became effective not more than three years </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
prior to the date hereof. The Company has also filed, or proposes to file, with the Commission pursuant to Rule&nbsp;424 under the Securities Act a prospectus supplement specifically relating to
the Securities (the &#147;Prospectus Supplement&#148;). The registration statement, as amended at the time it becomes effective, including the information, if any, deemed pursuant to Rule&nbsp;430A, 430B or 430C under the Securities Act to be part
of the registration statement at the time of its effectiveness (&#147;Rule&nbsp;430 Information&#148;), is referred to herein as the &#147;Registration Statement.&#148; As used herein, the term &#147;Prospectus&#148; means the Basic Prospectus as
supplemented by the prospectus supplement specifically relating to the Securities in the form first used to confirm sales (or made available upon request of purchasers pursuant to Rule 173 under the Securities Act) of the Securities and the term
&#147;Preliminary Prospectus&#148; means the preliminary prospectus supplement, if any, specifically relating to the Securities together with the Basic Prospectus. Capitalized terms used but not defined herein shall have the meanings given to such
terms in the Registration Statement and the Prospectus. References herein to the Registration Statement, the Basic Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by
reference therein. The terms &#147;supplement,&#148; &#147;amendment&#148; and &#147;amend&#148; as used herein with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and include any
documents filed by the Company under the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder (the &#147;Exchange Act&#148;) subsequent to the date of this Underwriting Agreement which are deemed to
be incorporated by reference therein. For purposes of this Underwriting Agreement, the term &#147;Effective Time&#148; means each effective date of the Registration Statement with respect to the offering of Securities, as determined for purposes of
Section&nbsp;11 of the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At or prior to 11:00 A.M., New York City time, on May 7, 2024 (the &#147;Time of Sale&#148;), the
Company will prepare certain information (collectively, the &#147;Time of Sale Information&#148;) which information will include the Preliminary Prospectus and which will be identified in Schedule 2 hereto for such offering of Securities as
constituting part of the Time of Sale Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Purchase of the Securities by the Underwriters</U>. (a)&nbsp;The Company agrees
to issue and sell the Securities to the several Underwriters named in Schedule&nbsp;1 hereto, and each Underwriter, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein,
agrees, severally and not jointly, to purchase from the Company the respective principal amount of Securities set forth opposite such Underwriter&#146;s name in Schedule&nbsp;1 hereto at a purchase price equal to 99.034% of the principal amount of
the Securities, plus accrued interest, if any, from May 16, 2024 to the Closing Date (as defined below), if settlement occurs after May 16, 2024. The Company will not be obligated to deliver any of the Securities except upon payment for all the
Securities to be purchased as provided herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The net purchase price for all the Securities to be purchased (the &#147;Net Purchase
Price&#148;) as provided herein will, on or about 10:00 A.M. (London time) on May&nbsp;16, 2024 (or at such other time and/or date as the Company and the Representatives may agree (the &#147;Closing Date&#148;)) be paid by, or on behalf of, the
Representatives to the Company against delivery of a global certificate (the &#147;Registered Global Certificate&#148;) in or substantially in the form provided in the Indenture, duly executed and registered in the name of USB Nominees (UK) Limited,
as nominee of Elavon Financial Services DAC, as common depositary (the &#147;Common Depositary&#148;) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for Euroclear Bank SA/NV (&#147;Euroclear&#148;) and for Clearstream Banking S.A. (&#147;Clearstream&#148;) and the registration of the holdings of the Securities represented by the Registered
Global Certificate in the register maintained by the registrar for the Securities, with any transfer taxes payable in connection with the sale of the Securities to be duly paid by the Company. The Registered Global Certificate will be made available
for inspection by the Representatives not later than 12:00 P.M., New York time, on the business day prior to the Closing Date. The payment of the Net Purchase Price by the Representatives to the Company against delivery of the Registered Global
Certificate as aforesaid shall be effected in the following manner: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Barclays Bank PLC or such other Representative as the Company may direct to settle the Securities (the
&#147;Settlement Representative&#148;) acknowledges that the Securities represented by the Registered Global Certificate will initially be credited to an account (the &#147;Commissionaire Account&#148;) for the benefit of the Settlement
Representative, the terms of which include a third-party beneficiary clause (<I>stipulation pour autrui</I>) with the Company as the third-party beneficiary and provide that such Securities are to be delivered to others only against payment of
monies representing the Net Purchase Price into the Commissionaire Account on a delivery against payment basis. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Settlement Representative acknowledges that (i)&nbsp;the Securities represented by the relevant Registered
Global Certificate shall be held to the order of the Company as set out above and (ii)&nbsp;the monies representing the Net Purchase Price received in the Commissionaire Account will be held on behalf of the Company until such time as they are
transferred to the Company&#146;s order. The Settlement Representative undertakes that the monies representing the Net Purchase Price will be transferred to the Company&#146;s order promptly following receipt of such monies in the Commissionaire
Account. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company acknowledges and accepts the benefit of the third-party beneficiary clause (<I>stipulation pour
autrui</I>) pursuant to the Belgian or Luxembourg Civil Code, as applicable, in respect of the Commissionaire Account. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Company acknowledges and agrees that the Underwriters named in this Underwriting Agreement are acting solely in the capacity of an
arm&#146;s length contractual counterparty to the Company with respect to any offering of Securities contemplated hereby (including in connection with determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an
agent of, the Company or any other person. Additionally, no such Underwriter is advising the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company shall consult with its own
advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and such Underwriters shall have no responsibility or liability to the Company with respect
thereto. Any review by such Underwriters named in this Underwriting Agreement of the Company, the transactions contemplated thereby or other matters relating to such transactions will be performed solely for the benefit of the Underwriters and shall
not be on behalf of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Representations and Warranties of the Company</U>. The Company represents and warrants
to each Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Registration Statement and Prospectus</U>. The Registration Statement is an &#147;automatic shelf
registration statement&#148; as defined under Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof, and no notice of objection of the Commission to the use of such registration
statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company. No order suspending the effectiveness of the Registration Statement has been issued by the Commission and, to the
Company&#146;s knowledge, no proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act against the Company or related to the offering has been initiated or threatened by the Commission; as of the Effective Time, the
Registration Statement complied in all material respects with the Securities Act and the Trust Indenture Act of 1939, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#147;Trust Indenture Act&#148;), and did
not or will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading; and as of the date of the Prospectus and any
amendment or supplement thereto and as of the Closing Date, the Prospectus did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation and warranty with respect to (i)&nbsp;that part of the Registration Statement that constitutes
the Statement of Eligibility <FONT STYLE="white-space:nowrap">(Form&nbsp;T-1)</FONT> of the Trustee under the Trust Indenture Act or (ii)&nbsp;the information contained in or omitted from the Prospectus, or any amendment or supplement thereto, in
reliance upon and in conformity with information furnished in writing to the Company by or on behalf of the Underwriters through the Representatives specifically for inclusion therein. The statistical and market-related data included in the
Prospectus are based on or derived from sources that the Company reasonably believes to be reliable and accurate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Time of Sale
Information</U>. The Time of Sale Information, at the Time of Sale and at the Closing Date did not and will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation and warranty with respect to any statements or omissions made in reliance upon and in conformity with information
relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in such Time of Sale Information. No statement of material fact included in the Prospectus has been omitted from the
Time of Sale Information and no statement of material fact included in the Time of Sale Information that is required to be included in the Prospectus has been omitted therefrom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Issuer Free Writing Prospectus</U>. The Company (including its agents and representatives, other than the Underwriters in their
capacity as such) has not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any &#147;written communication&#148; (as defined in Rule 405 under the Securities Act) that
constitutes an offer to sell or solicitation of an offer to buy the Securities (each such communication by the Company or its agents and representatives (other than a communication referred to in clauses (i), (ii) and (iii)&nbsp;below) an
&#147;Issuer Free Writing Prospectus&#148;) other than (i) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any document not constituting a prospectus pursuant to Section&nbsp;2(a)(10)(a) of the Securities Act or Rule 134 under the Securities Act, (ii)&nbsp;the Preliminary Prospectus, (iii)&nbsp;the
Prospectus, (iv)&nbsp;the documents listed on Schedule 2 hereto as constituting the Time of Sale Information and (v)&nbsp;any electronic road show or other written communications, in each case approved in writing in advance by the Representatives.
Each such Issuer Free Writing Prospectus complied in all material respects with the Securities Act, has been or will be (within the time period specified in Rule 433) filed in accordance with the Securities Act (to the extent required thereby) and,
when taken together with the Preliminary Prospectus accompanying, or delivered prior to delivery of, or filed prior to the first use of such Issuer Free Writing Prospectus, did not, and at the Closing Date will not, contain any untrue statement of a
material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation and warranty
with respect to any statements or omissions made in each such Issuer Free Writing Prospectus in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the
Representatives expressly for use in any Issuer Free Writing Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Incorporated Documents</U>. The documents incorporated<B>
</B>by reference in the Registration Statement, the Prospectus and the Time of Sale Information, when they were filed with the Commission, conformed in all material respects to the requirements of the Exchange Act, and any further documents so filed
and incorporated or deemed to be incorporated by reference in the Registration Statement or Prospectus, when such documents are filed with the Commission, will conform in all material respects to the requirements of the Exchange Act; and the
documents incorporated by reference in the Registration Statement and the Prospectus, when read together with the other information in the Registration Statement and the Prospectus, at the time filed did not, and at the Closing Date will not,
contain any untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>No Material Adverse Effect</U>. Since the respective dates as of which information is given in the Registration Statement, the Time of
Sale Information and the Prospectus, there has not been any material adverse change, or any development that would reasonably be likely to result in a material adverse change, in the general affairs, management, financial position,
stockholders&#146; equity or results of operations of the Company and its subsidiaries taken as a whole, whether or not in the ordinary course of business, in each case, otherwise than as set forth or contemplated in the Registration Statement, the
Time of Sale Information and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Organization and Good Standing</U>. The Company has been duly incorporated and is
validly existing as a corporation in good standing under the laws of the State of Delaware, with the corporate power and authority to own its properties and conduct its business as described in the Time of Sale Information and the Prospectus; the
Company is duly qualified as a foreign corporation to transact business and is in good standing in each other jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business,
except where the failure to qualify or to be in good standing would not have a material adverse effect on the general affairs, management, financial position, stockholders&#146; equity or results of operations of the Company and its subsidiaries
taken as a whole (a &#147;Material Adverse Effect&#148;); each of Canada Holding LLC, Gollek UK Limited, Keebler Company, Keebler </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Foods Company, Keebler Holding Corp., Kellogg Europe Company Limited, Kellogg Europe Treasury Services Unlimited Company, Kellogg Group Limited, Kellogg Group S.&agrave;.r.l., Kellogg Holding
Company Limited, Kellogg International Holding Company, Kellogg Irish Holding Limited, Kellogg Latin America Holding Company (One) Limited, Kellogg Lux III S. &agrave;r L., Kellogg North America Company and Kellogg Sales Company (collectively, the
&#147;Significant Subsidiaries&#148;) has been duly incorporated and is validly existing as a corporation in good standing under the laws of the jurisdiction of its incorporation, with the corporate power and authority to own its properties and
conduct its business as described in the Time of Sale Information and the Prospectus and is duly qualified as a foreign corporation to transact business and is in good standing in each other jurisdiction in which such qualification is required,
whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to qualify, to have been duly incorporated or to be in existence or good standing would not have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Capitalization</U>. All of the issued shares of capital stock of the Company have been duly and validly authorized and issued and are
fully paid and <FONT STYLE="white-space:nowrap">non-assessable;</FONT> except as otherwise disclosed in the Registration Statement, the Time of Sale Information and the Prospectus, all of the issued and outstanding capital stock or other ownership
interests of each Significant Subsidiary have been duly authorized and validly issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> and (except for shares necessary to qualify directors or to maintain any minimum number
of stockholders required by law or are immaterial to the Company&#146;s ability to control such Significant Subsidiary) are or, at the Closing Date will be, owned by the Company, directly or through subsidiaries, free and clear of any security
interest, mortgage, pledge, lien, encumbrance, claim or equity except (i)&nbsp;as described in the Registration Statement, the Time of Sale Information and the Prospectus and (ii)&nbsp;for such security interests, mortgages, pledges, liens,
encumbrances, claims or equities that are immaterial to the Company and the Significant Subsidiaries taken as a whole. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Due
Authorization</U>. This Underwriting Agreement has been duly authorized, executed and delivered by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>The Indenture</U>.
The Indenture has been duly authorized, executed and delivered by the Company and has been duly qualified under the Trust Indenture Act and constitutes a valid and legally binding agreement of the Company enforceable against the Company in
accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency or similar laws affecting the enforcement of creditors&#146; rights generally or by equitable principles relating to enforceability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>The Securities</U>. The Securities have been duly authorized and, when issued and authenticated in the manner provided for in the
Indenture and delivered as provided herein, will have been duly executed, authenticated, issued and delivered and will constitute valid and legally binding obligations of the Company, will be entitled to the benefits of the Indenture and will be
enforceable against the Company in accordance with the terms thereof, except as enforceability may be limited by applicable bankruptcy, insolvency or similar laws affecting the enforcement of creditors&#146; rights generally or by equitable
principles relating to enforceability. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <U>Descriptions of Documents</U>. The Indenture and the Securities will each conform, in
all material respects, to the descriptions thereof in the Registration Statement, the Time of Sale Information and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)
<U>No Violation or Default</U>. The issue and sale of the Securities and the compliance by the Company and the Significant Subsidiaries, as applicable, with all of the provisions of the Securities, the Indenture, this Underwriting Agreement and the
consummation of the transactions contemplated herein and therein, will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any lien,
charge or encumbrance upon any of the property or assets of the Company or any of the Significant Subsidiaries pursuant to the terms of, any indenture, mortgage, deed of trust, loan or credit agreement or other agreement or instrument to which the
Company or any of the Significant Subsidiaries is a party or by which the Company or any of the Significant Subsidiaries is bound or to which any of the property or assets of the Company or any of the Significant Subsidiaries is subject, except
where any such conflict, breach, violation, default, creation or imposition (individually or in the aggregate) would not reasonably be expected to have a Material Adverse Effect or a material adverse effect on the ability of the Company and the
Significant Subsidiaries to perform their respective obligations hereunder; nor will such action result in any violation of the provisions of the Restated Certificate of Incorporation, as amended, or the
<FONT STYLE="white-space:nowrap">By-Laws</FONT> of the Company, or the charter or bylaws of the Significant Subsidiaries; nor will such action result in any violation of the provisions of any statute or law or any order, rule or regulation of any
court or governmental agency or body having jurisdiction over the Company or any of the Significant Subsidiaries or any of their properties, except where any such violation (individually or in the aggregate) would not reasonably be expected to have
a Material Adverse Effect or a material adverse effect on the ability of the Company and the Significant Subsidiaries to perform their respective obligations hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <U>No Consents Required</U>. No consent, approval, authorization, order, registration, filing or qualification of or with any court or
governmental agency or body having jurisdiction over the Company or any of the Significant Subsidiaries or any of their properties is required for the issue and sale of the Securities or the consummation of the other transactions contemplated by the
Indenture and this Underwriting Agreement, except for such consents, approvals, authorizations, orders, registrations, filings or qualifications which shall have been obtained or made prior to the Closing Date or as may be required by the securities
or blue sky laws of the various states, the Securities Act, the Trust Indenture Act and the securities laws of any jurisdiction outside the United States in which the Securities are offered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <U>Legal Proceedings</U>. Other than as set forth in the Registration Statement, the Time of Sale Information or the Prospectus, there are
no legal or governmental proceedings pending to which the Company or any of its subsidiaries is a party or of which any property of the Company or any of its subsidiaries is the subject which would reasonably be expected to, individually or in the
aggregate, have a Material Adverse Effect or which would materially and adversely affect the consummation of the transactions contemplated under this Underwriting Agreement or the Indenture; and, to the best of the Company&#146;s knowledge, no such
proceedings are threatened or contemplated by governmental authorities or threatened by others. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <U>PricewaterhouseCoopers LLP</U>. PricewaterhouseCoopers LLP, who have audited certain
financial statements of each of the Company and its subsidiaries and delivered their reports with respect to the audited financial statements of each of the Company and its subsidiaries, is an independent registered public accounting firm with
respect to the Company within the applicable rules and regulations thereunder adopted by the Commission and the Public Company Accounting Oversight Board (United States). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) <U>Financial Statements</U>. The financial statements of the Company and its subsidiaries included or incorporated by reference in the
Registration Statement, the Time of Sale Information and Prospectus present fairly in all material respects the financial condition, results of operations and cash flows of each of the Company and its consolidated subsidiaries as of the dates and
for the periods indicated, comply in all material respects as to form with the applicable accounting requirements of the Securities Act and the Exchange Act, as applicable, and have been prepared in conformity with generally accepted accounting
principles applied on a consistent basis throughout the periods involved (except as otherwise noted therein); the selected financial data set forth under the captions &#147;Selected Consolidated Financial Data&#148; and &#147;Capitalization&#148; in
the Time of Sale Information and the Prospectus fairly present in all material respects, the information included therein. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus presents fairly the information called for in all material respects and is prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) <U>Disclosure Controls</U>. The Company maintains required &#147;disclosure controls and procedures&#148; (as defined in Rules <FONT
STYLE="white-space:nowrap">13a-15(e)</FONT> and <FONT STYLE="white-space:nowrap">15d-15(e)</FONT> under the Exchange Act) and the Company&#146;s &#147;disclosure controls and procedures&#148; are designed to provide reasonable assurance that<I>
</I>material information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is communicated to the Company&#146;s management as appropriate to allow timely decisions regarding required disclosure.
The Company and its subsidiaries have carried out evaluations of the effectiveness of their disclosure controls and procedures as required by Rule <FONT STYLE="white-space:nowrap">13a-15</FONT> of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) <U>Accounting Controls</U><I>.</I> The Company &#147;maintains a system of internal control over financial reporting&#148; (as such term
is defined in Rule <FONT STYLE="white-space:nowrap">13a-15(f)</FONT> of the Exchange Act) that complies with the requirements of the Exchange Act and has been designed by the Company&#146;s principal executive officer and principal financial
officer, or under their supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; as
of December&nbsp;30, 2023, the Company&#146;s internal control over financial reporting is effective and, except as otherwise disclosed in the Registration Statement, the Time of Sale Information and the Prospectus, the Company is not aware of any
changes in its internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) <U>Sarbanes-Oxley Act</U>. The Company is in compliance in all material respects with all applicable provisions of the Sarbanes-Oxley Act
of 2002 and the rules and regulations promulgated in connection therewith. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) <U>Compliance with Environmental Laws</U>. Neither the Company nor any of its
subsidiaries is in violation of any statute, any rule, regulation, decision or order of any governmental agency or body or any court, domestic or foreign, relating to the use, disposal or release of hazardous or toxic substances or relating to the
protection or restoration of the environment or human exposure to hazardous or toxic substances (collectively, &#147;Environmental Laws&#148;), owns or operates any real property contaminated with any substance that is subject to any environmental
laws, is liable for any <FONT STYLE="white-space:nowrap">off-site</FONT> disposal or contamination pursuant to any environmental laws, or is subject to any claim relating to any environmental laws, which violation, contamination, liability or claim
would individually or in the aggregate have a Material Adverse Effect; and the Company is not aware of any pending investigation which might lead to such a claim. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) <U>Title to Intellectual Property</U>. The Company and the Significant Subsidiaries own, possess, license or have other rights to use, on
reasonable terms, all patents, patent applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade secrets, technology, <FONT STYLE="white-space:nowrap">know-how</FONT> and other
intellectual property (collectively, the &#147;Intellectual Property&#148;) necessary for the conduct of their respective businesses as now conducted free and clear of any material security interests, claims, liens or encumbrances, except as would
not reasonably be expected to have a Material Adverse Effect or as set forth in or contemplated in the Registration Statement, the Time of Sale Information and the Prospectus; and none of the Intellectual Property, to the knowledge of the Company,
conflicts with the valid trademark, trade name, copyright, patent, patent right or intangible asset of any other person to the extent that such conflict has or would reasonably be expected to have a Material Adverse Effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) <U>Investment Company</U>. The Company is not, and upon the issuance and sale of the Securities as herein contemplated and the application
of the net proceeds therefrom as described in the Time of Sale Information and the Prospectus will not be, an &#147;investment company&#148; within the meaning of the Investment Company Act of 1940, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) <U>No Stabilization</U>. (i)&nbsp;Neither the Company nor any of its affiliates nor any person acting on its or their behalf (other than
the Underwriters, as to whom the Company makes no representation) has taken, directly or indirectly, any action designed to cause or that constituted or that might reasonably be expected to cause or constitute, under the Exchange Act or otherwise,
the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities; (ii)&nbsp;the Company has not issued and will not issue, without the prior consent of the Representatives, on behalf of
the Underwriters, any press or other public announcement referring specifically to the proposed issue of, or the terms of, the Securities unless the announcement adequately discloses that stabilizing action may take place in relation to the
Securities (but only to the extent required by laws, regulators or guidelines (including the United Kingdom&#146;s Financial Conduct Authority Handbook) applicable to the Company, the Underwriters, the Representatives or any other entity undertaking
stabilization in connection with the issue of the Securities) and the Company authorizes the Representatives to make all appropriate disclosure in relation to stabilization instead of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) <U>Forward-Looking Statements</U>. No forward-looking statement (within the meaning of
Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the Exchange Act) contained or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus has been made or reaffirmed without a reasonable
basis or has been disclosed other than in good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) <U>Status Under the Securities Act.</U> The Company was a &#147;well-known
seasoned issuer&#148; as defined in Rule 405 under the Securities Act (A)&nbsp;at the time of filing the Registration Statement, (B)&nbsp;at the time of the most recent amendment to the Registration Statement for the purpose of complying with
Section&nbsp;10(a)(3) of the Securities Act (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Section&nbsp;13 or 15(d) of the Exchange Act or form of prospectus filed pursuant to the Securities Act), and
(C)&nbsp;at the time the Company or any person acting on its behalf (within the meaning, for this clause only, of Rule 163(c) under the Securities Act) made any offer relating to the Securities in reliance on the exemption of Rule 163 under the
Securities Act; and the Company was not an &#147;ineligible issuer&#148; as defined in Rule 405 under the Securities Act at the earliest time after the filing of the Registration Statement that the Company or any Underwriter made a bona fide offer
(within the meaning of Rule 164(h)(2) under the Securities Act) of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Further Agreements of the Company</U>. The
Company covenants and agrees with each Underwriter that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Filings with the Commission</U>. The Company will file the Prospectus in a
form approved by the Underwriters with the Commission pursuant to Rule&nbsp;424 under the Securities Act not later than the close of business on the second business day following the date of determination of the public offering price of the
Securities or, if applicable, such earlier time as may be required by Rule&nbsp;424(b) and Rule&nbsp;430A, 430B or 430C under the Securities Act. The Company will file any Issuer Free Writing Prospectus (including the Term Sheet in the form of
Schedule 3 to this Underwriting Agreement) to the extent required by Rule 433 under the Securities Act; and the Company will furnish copies of the Prospectus to the Underwriters in New York City prior to 10:00&nbsp;A.M., New York City time, on the
second day succeeding the date of this Underwriting Agreement in such quantities as the Representatives may reasonably request. If at any time when Securities remain unsold by the Underwriters the Company receives from the Commission a notice
pursuant to Rule 401(g)(2) or otherwise ceases to be eligible to use the automatic shelf registration statement form, the Company will (i)&nbsp;promptly notify the Underwriters and (ii)&nbsp;subject to paragraph (d), promptly take such action as
shall be necessary to permit the public offering and sale of the Securities to continue as soon as practicable after receipt of such notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Filing Fees</U>. The Company agrees to pay the required Commission filing fees relating to the Securities within the time required by
Rule&nbsp;456(b)(1) of the Securities Act without regard to the proviso therein and otherwise in accordance with Rules&nbsp;456(b) and 457(r) of the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Delivery of Copies</U>. The Company will deliver, without charge, to each Underwriter during the Prospectus Delivery Period (as defined
below), as many copies of the Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein) and each Issuer Free Writing Prospectus (if applicable) as the Representatives may reasonably request. As
used herein, the term &#147;Prospectus Delivery Period&#148; means such period of time after the first date of the public offering of the Securities as in the opinion of counsel for the Underwriters a prospectus relating to the Securities is
required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Securities by any Underwriter or dealer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Amendments or Supplements; Issuer Free Writing Prospectuses</U>. Before making,
preparing, using, authorizing, approving, referring to or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement or the Prospectus, the Company will furnish to the Representatives and
counsel for the Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such
proposed amendment or supplement to which the Representatives reasonably object. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Notice to the Representatives</U><I>.</I> The
Company will advise the Representatives promptly, and confirm such advice in writing, (i)&nbsp;when any amendment to the Registration Statement has been filed or becomes effective; (ii)&nbsp;when any supplement to the Prospectus or any amendment to
the Prospectus or any Issuer Free Writing Prospectus has been filed; (iii)&nbsp;of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt of any comments from the
Commission relating to the Registration Statement or any other request by the Commission for any additional information; (iv)&nbsp;of the issuance by the Commission of any order suspending the effectiveness of the Registration Statement or
preventing or suspending the use of any Preliminary Prospectus or the Prospectus or the initiation or threatening of any proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act; (v)&nbsp;of the occurrence of any event within
the Prospectus Delivery Period as a result of which the Prospectus, the Time of Sale Information or any Issuer Free Writing Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus, the Time of Sale Information or any Issuer Free Writing Prospectus is delivered to a purchaser,
not misleading; and (vi)&nbsp;of the receipt by the Company of any notice with respect to any suspension of the qualification of the Securities for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for such
purpose; and the Company will use its reasonable best efforts to prevent the issuance of any such order suspending the effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus or the Prospectus or
suspending any such qualification of the Securities and, if any such order is issued, will obtain as soon as possible the withdrawal thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Time of Sale Information</U><I>.</I> If at any time prior to the Closing Date (i)&nbsp;any event shall occur or condition shall exist
as a result of which the Time of Sale Information as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the
circumstances, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Time of Sale Information to comply with law, the Company will immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph
(d)&nbsp;above, file with the Commission (to the extent required) and furnish to the Underwriters and to such dealers as the Representatives may designate, such amendments or supplements to the Time of Sale Information as may be necessary so that
the statements in the Time of Sale Information as so amended or supplemented will not, in the light of the circumstances, be misleading or so that the Time of Sale Information will comply with law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Ongoing Compliance</U><I>. </I>If during the Prospectus Delivery Period (i)&nbsp;any
event shall occur or condition shall exist as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in
order to make the statements therein, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Prospectus to comply with law, the Company will
immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph (d)&nbsp;above, file with the Commission and furnish to the Underwriters and to such dealers as the Representatives may designate, such amendments or
supplements to the Prospectus as may be necessary so that the statements in the Prospectus as so amended or supplemented will not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that
the Prospectus will comply with law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Blue Sky Compliance</U>. The Company will arrange, if necessary, for the qualification of the
Securities for sale by the Underwriters under the laws of such jurisdictions as the Representatives may reasonably designate and will maintain such qualifications in effect so long as required for the sale of the Securities; <U>provided</U> that in
no event shall the Company be obligated to qualify to do business in any jurisdiction where it is not now so qualified or to take any action that would subject it to service of process in suits in any jurisdiction where it is not now so subject or
subject themselves to taxation in any such jurisdiction where it is not then so subject. The Company will promptly advise the Representatives of the receipt by the Company of any notification with respect to the suspension of the qualification of
the Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Book-Entry</U>.
The Company will cooperate with the Underwriters and use its reasonable best efforts to permit the Securities to be eligible for clearance and settlement through Clearstream and Euroclear. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>Clear Market</U>. The Company will not during the period from the date hereof through and including the Closing Date, without the prior
written consent of the Representatives, offer, sell, contract to sell, grant any other option to purchase or otherwise dispose of (or enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition
(whether by actual disposition or effective economic disposition due to cash settlement or otherwise) by the Company or any affiliate of the Company or any person in privity with the Company or any affiliate of the Company), directly or indirectly,
or announce the offering of, any debt securities issued or guaranteed by the Company (other than the Securities, $300,000,000&nbsp;million aggregate principal amount of the Company&#146;s 5.750% Senior Notes due 2054 and commercial paper). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <U>No Stabilization</U>. (i)&nbsp;The Company will not take, directly or indirectly, any
action designed to or that would constitute or that might reasonably be expected to cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale
of the Securities; (ii)&nbsp;the Company will not issue, without the prior consent of the Representatives, on behalf of the Underwriters, any press or other public announcement referring specifically to the proposed issue of, or the terms of, the
Securities unless the announcement adequately discloses that stabilizing action may take place in relation to the Securities (but only to the extent required by laws, regulators or guidelines (including the United Kingdom&#146;s Financial Conduct
Authority Handbook) applicable to the Company, the Underwriters, the Representatives or any other entity undertaking stabilization in connection with the issue of the Securities). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <U>Use of Proceeds</U>. The Company will use the net proceeds received by it from the sale of the Securities in the manner specified in
the Time of Sale Information and the Prospectus under the caption &#147;Use of Proceeds.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <U>Earning Statement</U><I>.</I> The
Company will make generally available to its security holders as soon as practicable an earning statement that satisfies the provisions of Section&nbsp;11(a) of the Securities Act and Rule&nbsp;158 of the Commission promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <U>Filing of Exchange Act Documents</U><I>.</I> The Company will file promptly all reports and any definitive proxy or information
statements required to be filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act during the Prospectus Delivery Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <U>Record Retention</U>. The Company will, pursuant to reasonable procedures developed in good faith, retain copies of each Issuer Free
Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) <U>Listing</U>. The
Company will use its reasonable best efforts to cause the Securities to be listed for trading on the New York Stock Exchange (&#147;NYSE&#148;) as promptly as practicable after the issuance of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) <U>Stabilization</U><I>. </I>In connection with the issuance of the Securities, the Company hereby authorizes one or more of the
Underwriters (each a &#147;Stabilizing Manager&#148; and, together, the &#147;Stabilizing Managers&#148;) (or any person acting on behalf of the Stabilizing Managers) to over-allot securities or effect transactions with a view to supporting the
market price of the Securities at a level higher than that which might otherwise prevail in accordance with applicable laws and regulations. However, the Company acknowledges and agrees that stabilization might not necessarily occur. The Company
hereby acknowledges and agrees that any loss or profit sustained as a consequence of any such over-allotment or stabilization shall be for the account of the Stabilizing Manager. The Company hereby confirms the authority of Co&ouml;peratieve
Rabobank U.A. to make adequate public disclosure of information, and to act as the central point responsible for handling any request from a competent authority, in each case as required by Article 6(5) of Commission Delegated Regulation (EU)
2016/1052 of March&nbsp;8, 2016 with regard to regulatory technical standards for the conditions applicable to <FONT STYLE="white-space:nowrap">buy-back</FONT> programs and stabilization measures as it forms part of United Kingdom domestic law by
virtue of the European Union (Withdrawal) Act 2018 (as amended, the &#147;EUWA&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Certain Agreements of the Underwriters</U>.
Each Underwriter hereby makes the representations and warranties set forth in Annex A hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Conditions of Underwriters&#146; Obligations</U>. The obligation of each Underwriter
to purchase Securities on the Closing Date as provided herein is subject to the performance by the Company of its covenants and other obligations hereunder and to the following additional conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Registration Compliance; No Stop Order</U><I>.</I> No order suspending the effectiveness of the Registration Statement shall be in
effect, and no proceeding for such purpose or pursuant to Section&nbsp;8A under the Securities Act shall be pending before or threatened by the Commission, and no notice of objection of the Commission to use the Registration Statement or any
post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act shall have been received; the Prospectus and each Issuer Free Writing Prospectus shall have been timely filed with the Commission under the Securities Act and in
accordance with Section&nbsp;4(a) hereof; and all requests by the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Representations and Warranties</U><I>.</I> The representations and warranties of the Company contained herein shall be true and correct
in all material respects on the date hereof and on and as of the Closing Date; and the statements of the Company and its officers made in any certificates delivered pursuant to this Underwriting Agreement shall be true and correct in all material
respects on and as of the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>No Downgrade</U><I>.</I> Subsequent to the earlier of (A)&nbsp;the Time of Sale and
(B)&nbsp;the execution and delivery of this Underwriting Agreement, and prior to the Closing Date, there shall not have been any decrease in the rating of any of the Company&#146;s debt securities by any &#147;nationally recognized statistical
rating organization&#148; (as defined in Section&nbsp;3(a)(62) of the Exchange Act) and no such organization shall have publicly announced that it has under surveillance or review (other than an announcement with positive implications of a possible
upgrade), its rating of the Company&#146;s debt securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>No Material Adverse Effect</U><I>.</I> Subsequent to the execution and
delivery of this Underwriting Agreement, or, if earlier, the date of the latest financial statements included in the Time of Sale Information and the Prospectus, there has not been any change, or any development involving a prospective change, in or
affecting the condition (financial or otherwise), prospects, earnings, business or properties of the Company and its subsidiaries, taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth or
contemplated in the Time of Sale Information (excluding any amendment or supplement thereto) and the Prospectus, the effect of which is, in the judgment of the Representatives, so material and adverse as to make it impracticable or inadvisable to
market the Securities as contemplated by this Underwriting Agreement, the Time of Sale Information and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)
<U>Officer&#146;s Certificate</U><I>.</I> The Representatives shall have received on and as of the Closing Date a certificate of an executive officer of the Company who has specific knowledge of the Company&#146;s financial matters and is
satisfactory to the Representatives confirming that such officer has carefully reviewed the Registration Statement, the Time of Sale Information and the Prospectus and, to the best knowledge of such officer, (i)&nbsp;the representations set forth in
Sections&nbsp;3(a) and 3(b) hereof are true and correct, (ii)&nbsp;the other representations and warranties of the Company in this Underwriting Agreement are true and correct and that the Company has complied with all agreements and satisfied all
conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date and (iii)&nbsp;to the effect set forth in paragraphs (a), (c)&nbsp;and (d)&nbsp;above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Comfort Letters</U><I>.</I> On the date of this Underwriting Agreement and on the
Closing Date, PricewaterhouseCoopers LLP shall have furnished to the Representatives, at the request of the Company, letters, dated the respective dates of delivery thereof and addressed to the Underwriters, in form and substance reasonably
satisfactory to the Representatives containing statements and information of the type customarily included in accountants&#146; &#147;comfort letters&#148; to underwriters with respect to the financial statements and certain financial information
contained or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus; <U>provided</U> that the letter delivered on the Closing Date shall use a
<FONT STYLE="white-space:nowrap">&#147;cut-off&#148;</FONT> date no more than three business days prior to the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)
<U>Opinion of <FONT STYLE="white-space:nowrap">In-House</FONT> Counsel for the Company</U><I>.</I> John Min, Senior Vice President, Chief Legal Officer and Secretary of the Company, shall have furnished to the Representatives, at the request of the
Company, his written opinion, dated the Closing Date and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, to the effect set forth in Annex B hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Opinion of Counsel for the Company</U><I>.</I> Kirkland&nbsp;&amp; Ellis LLP, counsel for the Company, shall have furnished to the
Representatives, at the request of the Company, their written opinion, dated the Closing Date and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, to the effect set forth in Annex C hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Opinion of Counsel for the Underwriters</U><I>.</I> The Representatives shall have received on and as of the Closing Date an opinion of
Mayer Brown LLP, counsel for the Underwriters, with respect to such matters as the Representatives may reasonably request, and such counsel shall have received such documents and information as they may reasonably request to enable them to pass upon
such matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <U>No Legal Impediment to Issuance</U><I>.</I> No action shall have been taken and no statute, rule, regulation or
order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Securities; and no injunction or order of any federal,
state or foreign court shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)
<U>Clearance</U>. The Securities shall be eligible for clearance and settlement through Clearstream and Euroclear. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <U>Listing</U><I>.
</I>On or prior to the Closing Date, an application for the listing of the Securities shall have been submitted to the NYSE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)
<U>Additional Documents</U><I>.</I> On or prior to the Closing Date, the Company shall have furnished to the Representatives such further certificates and documents as the Representatives may reasonably request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All opinions, letters, certificates and evidence mentioned above or elsewhere in this
Underwriting Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Indemnification and Contribution</U>. <B></B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Indemnification of the Underwriters</U><I>.</I> The Company agrees to indemnify and hold harmless each Underwriter, its affiliates,
directors and officers and each person, if any, who controls such Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, from and against any and all losses, claims, damages and liabilities
(including, without limitation, reasonable legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted as such fees and expenses are incurred), joint or several, that (i)&nbsp;arise out of, or are
based upon, any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, or are caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary in
order to make the statements therein, not misleading, or (ii)&nbsp;arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement thereto), any Issuer
Free Writing Prospectus or any Time of Sale Information, or are caused by any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances under which they were made,
not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with any
information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Indemnification of the Company</U><I>.</I> Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the
Company, its directors, its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act to the same extent as the
indemnity set forth in paragraph (a)&nbsp;above, but only with respect to any losses, claims, damages or liabilities that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon
and in conformity with any information relating to such Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the Registration Statement, the Prospectus (or any amendment or supplement
thereto) any Issuer Free Writing Prospectus or any Time of Sale Information, it being understood and agreed that the only such information consists of the information in the last paragraph on the cover page of the Prospectus, the information in the
table on Page <FONT STYLE="white-space:nowrap">S-32</FONT> listing the &#147;Underwriters&#148; and &#147;Principal Amount of Notes&#148; and the information in the third, sixth and seventh paragraphs and the fifth sentence of the ninth paragraph
under the caption &#147;Underwriting (Conflicts of Interest)&#148; beginning on page <FONT STYLE="white-space:nowrap">S-32</FONT> of the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Notice and Procedures</U><I>.</I> If any suit, action, proceeding (including any governmental or regulatory investigation), claim or
demand shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to either paragraph (a)&nbsp;or (b)&nbsp;above, such person (the &#147;Indemnified Person&#148;) shall promptly notify the person
against whom such indemnification may be sought (the &#147;Indemnifying Person&#148;) in writing; <U>provided</U> that </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have under this Section&nbsp;7 except to the extent that it has been materially prejudiced
(through the forfeiture of substantive rights or defenses) by such failure; and <U>provided</U>, <U>further</U>, that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have to an Indemnified Person
otherwise than under this Section&nbsp;7. If any such proceeding shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the Indemnifying Person shall retain counsel reasonably
satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified Person and any others entitled to indemnification pursuant to this
Section&nbsp;7 that the Indemnifying Person may designate in such proceeding and shall pay the reasonable fees and expenses of such proceeding and shall pay the fees and expenses of counsel related to such proceeding as incurred. In any such
proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless (i)&nbsp;the Indemnifying Person and the Indemnified Person shall
have mutually agreed to the contrary; (ii)&nbsp;the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the Indemnified Person; (iii)&nbsp;the Indemnified Person shall have reasonably concluded that
there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or (iv)&nbsp;the named parties in any such proceeding (including any impleaded parties) include both the Indemnifying
Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or potential differing interests between them. It is understood and agreed that the Indemnifying Person shall not, in
connection with any proceeding or related proceeding in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses
shall be reimbursed as they are incurred. Any such separate firm for any Underwriter, its affiliates, directors and officers and any control persons of such Underwriter shall be designated in writing by the Representatives and any such separate firm
for the Company, its directors, its officers who signed the Registration Statement and any control persons of the Company shall be designated in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding
effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such
settlement or judgment. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified Person for reasonable fees and expenses of counsel as contemplated by
this paragraph, the Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i)&nbsp;such settlement is entered into more than 60&nbsp;days after receipt by the Indemnifying Person of such
request and (ii)&nbsp;the Indemnifying Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement. No Indemnifying Person shall, without the written consent of the Indemnified Person,
effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement
(x)&nbsp;includes an unconditional release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y)&nbsp;does not
include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Contribution</U><I>.</I> If the indemnification provided for in paragraphs
(a)&nbsp;and (b)&nbsp;above is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such paragraph, in lieu of indemnifying such
Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits
received by the Company on the one hand and the Underwriters on the other from the offering of the Securities or (ii)&nbsp;if the allocation provided by clause (i)&nbsp;is not permitted by applicable law, in such proportion as is appropriate to
reflect not only the relative benefits referred to in clause (i)&nbsp;but also the relative fault of the Company on the one hand and the Underwriters on the other in connection with the statements or omissions that resulted in such losses, claims,
damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Underwriters on the other shall be deemed to be in the same respective proportions as the net
proceeds (before deducting expenses) received by the Company from the sale of the Securities and the total underwriting discounts and commissions received by the Underwriters in connection therewith, in each case as set forth in the table on the
cover of the Prospectus, bear to the aggregate offering price of the Securities. The relative fault of the Company on the one hand and the Underwriters on the other shall be determined by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters and the parties&#146; relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Limitation on Liability</U><I>.</I> The Company and the
Underwriters agree that it would not be just and equitable if contribution pursuant to this Section&nbsp;7 were determined by <U>pro</U> <U>rata</U> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other
method of allocation that does not take account of the equitable considerations referred to in paragraph (d)&nbsp;above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in
paragraph (d)&nbsp;above shall be deemed to include, subject to the limitations set forth above, any reasonable legal or other expenses incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions
of this Section&nbsp;7, in no event shall an Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the
Securities exceeds the amount of any damages that such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the
meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters&#146; obligations to contribute pursuant to this Section&nbsp;7 are
several in proportion to their respective purchase obligations hereunder and not joint. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)
<U><FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Remedies</U><I>.</I> The remedies provided for in this Section&nbsp;7 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Person at
law or in equity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Termination</U>. This Underwriting Agreement may be terminated in the absolute
discretion of the Representatives, by notice to the Company, if after the execution and delivery of this Underwriting Agreement and prior to the Closing Date (i)&nbsp;trading generally shall have been suspended or materially limited on the NYSE or
the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (ii)&nbsp;trading of any securities issued or guaranteed by the Company shall have been suspended on any exchange or in any <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or minimum prices shall have been established on the NYSE or in any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (iii)&nbsp;a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities or by
European Union authorities; or (iv)&nbsp;there shall have occurred any outbreak or escalation of hostilities, declaration by the United States or a member of the European Union of a national emergency or war or any change in financial markets or any
calamity or crisis, either within or outside the United States, that, in the judgment of the Representatives, is so material and adverse as to make it, in the judgment of the Representatives, impracticable or inadvisable to proceed with the
offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Underwriting Agreement, the Time of Sale Information and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Defaulting Underwriter</U>. (a)&nbsp;If, on the Closing Date, any Underwriter defaults on its obligation to purchase the Securities that
it has agreed to purchase hereunder, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters may in their discretion arrange for the purchase of such Securities by other persons satisfactory to the Company on the terms contained in
this Underwriting Agreement. If, within 36 hours after any such default by any Underwriter, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters do not arrange for the purchase of such Securities, then the Company shall be
entitled to a further period of 36 hours within which to procure other persons satisfactory to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters to purchase such Securities on such terms. If other persons become obligated or
agree to purchase the Securities of a defaulting Underwriter, either the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or the Company may postpone the Closing Date for up to five full business days in order to effect any
changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement and the Prospectus or in any other document or arrangement, and the Company agrees to promptly prepare any
amendment or supplement to the Registration Statement and the Prospectus that effects any such changes. As used in this Underwriting Agreement, the term &#147;Underwriter&#148; includes, for all purposes of this Underwriting Agreement unless the
context otherwise requires, any person not listed in this Underwriting Agreement that, pursuant to this Section&nbsp;9, purchases Securities that a defaulting Underwriter agreed but failed to purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains unpurchased does not exceed
<FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate principal amount of all the Securities, then the Company shall have the right to require each <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter to purchase the
principal amount of Securities that such Underwriter agreed to purchase hereunder plus such Underwriter&#146;s <U>pro</U> <U>rata</U> share (based on the principal amount of Securities that such Underwriter agreed to purchase hereunder) of the
Securities of such defaulting Underwriter or Underwriters for which such arrangements have not been made. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If, after giving effect to any arrangements for the purchase of the Securities of a
defaulting Underwriter or Underwriters by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains unpurchased
exceeds <FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate principal amount of all the Securities, or if the Company shall not exercise the right described in paragraph (b)&nbsp;above, then this Underwriting Agreement shall
terminate without liability on the part of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters. Any termination of this Underwriting Agreement pursuant to this Section&nbsp;9 shall be without liability on the part of the Company,
except that the Company will continue to be liable for the payment of expenses as set forth in Section&nbsp;10 hereof and except that the provisions of Section&nbsp;7 hereof shall not terminate and shall remain in effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter for damages caused by its default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Payment of Expenses</U><I>.</I>
(a)&nbsp;Whether or not the transactions contemplated by this Underwriting Agreement are consummated or this Underwriting Agreement is terminated, the Company will pay or cause to be paid all costs and expenses incident to the performance of its
obligations hereunder, including without limitation, (i)&nbsp;the copying and distribution of the Indenture and the preparation of the certificates representing the Securities; (ii)&nbsp;the costs incident to the preparation, printing and filing
under the Securities Act of the Registration Statement, any Preliminary Prospectus and the Prospectus (including all exhibits, amendments and supplements thereto) and the distribution thereof and the listing of the Securities on the NYSE;
(iii)&nbsp;the printing (or reproduction) and delivery (including postage, air freight charges and charges for counting and packaging) of such copies of any Preliminary Prospectus Supplement, any Issuer Free Writing Prospectus, any Time of Sale
Information and the Prospectus, and all amendments or supplements to either of them, as may, in each case, be reasonably requested for use in connection with the offering and sale of the Securities; (iv)&nbsp;the preparation, printing,
authentication, issuance and delivery of certificates for the Securities, including any stamp or transfer taxes in connection with the original issuance and sale of the Securities; (v)&nbsp;the printing (or reproduction) and delivery of this
Underwriting Agreement and all other agreements or documents printed (or reproduced) and delivered in connection with the offering of the Securities; (vi)&nbsp;the fees and expenses incurred in connection with the registration or qualification and
determination of eligibility for investment of the Securities under the securities or blue sky laws of such jurisdictions as the Representatives may designate (including filing fees) and the preparation, printing and distribution of a Blue Sky
Memorandum (including the related reasonable fees and expenses of counsel for the Underwriters); (vii) the transportation and other expenses incurred by or on behalf of Company representatives in connection with presentations to prospective
purchasers of the Securities; (viii)&nbsp;the fees and expenses of the Company&#146;s accountants and the fees and expenses of counsel (including local and special counsel) for the Company; (ix)&nbsp;any fees charged by securities rating services
for rating the Securities; (x)&nbsp;the fees and expenses of the Trustee and any agent of the Trustee, including any paying agent, and the fees and disbursements of counsel for the Trustee in connection with the Indenture and the Securities;
(xi)&nbsp;all expenses and application fees incurred in connection with any filing with, and clearance of any offering by the Financial Industry Regulatory Authority, Inc.; (xii)&nbsp;all fees and expenses (including reasonable fees and expenses of
counsel) in connection with the approval of the Securities by Clearstream and Euroclear for book-entry transfer; and (xiii)&nbsp;all other costs and expenses incurred by the Company incident to the performance by the Company of its obligations
hereunder. It is understood, however, that except as provided in this Section&nbsp;10 and Section&nbsp;7, the Underwriters shall pay their own expenses on a pro rata basis in accordance with the amount of Securities purchased by such Underwriter as
set forth on <U>Schedule 1</U>, including the fees and disbursements of their counsel. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If (i)&nbsp;this Underwriting Agreement is terminated pursuant to Section&nbsp;8,
(ii)&nbsp;the Company for any reason fails to tender the Securities for delivery to the Underwriters or (iii)&nbsp;the Underwriters decline to purchase the Securities for any reason permitted under this Underwriting Agreement, the Company agrees to
reimburse the Underwriters for all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses (including the fees and expenses of their counsel) reasonably incurred by the Underwriters in
connection with this Underwriting Agreement and the offering contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Stabilization</U>. If an Underwriter (or persons
acting on its behalf), in connection with the distribution of the Securities, offers Securities in excess of the aggregate principal amount to be issued or effects transactions with a view to supporting the market price of the Securities at levels
other than those which might otherwise prevail in the open market, such person(s) shall not in doing so be deemed to act as an agent of the Company. The Company will not as a result of any action taken by an Underwriter (or persons acting on its
behalf), under this clause be obliged to issue Securities in excess of the aggregate amount of Securities to be issued under this Underwriting Agreement, nor shall the Company be liable for any loss, or entitled to any profit, arising from any
excess offers or stabilization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Agreement Among Managers</U>. By executing this Underwriting Agreement, each of the Underwriters
hereby agrees to be bound by the provisions of the ICMA Agreement Among Managers Version 1 (Fixed-Price Non Equity-Related Issues)/New York Law Schedule (the &#147;AAM&#148;) save that in the event of any conflict between the provisions of the AAM
and this Underwriting Agreement, the terms of this Underwriting Agreement shall prevail. For the purposes of the AAM, &#147;Managers&#148; means the Underwriters and the Representatives shall be &#147;Lead Managers.&#148; &#147;Settlement Lead
Manager&#148; and &#147;Stabilizing Manager&#148; means Co&ouml;peratieve Rabobank U.A. and &#147;Subscription Agreement&#148; means this Underwriting Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Persons Entitled to Benefit of Agreement</U>. This Underwriting Agreement shall inure to the benefit of and be binding upon the parties
hereto and their respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates of each Underwriter referred to in Section&nbsp;7 hereof. Nothing in this Underwriting Agreement is intended or
shall be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Underwriting Agreement or any provision contained herein. No purchaser of Securities from any Underwriter shall be deemed to be a
successor merely by reason of such purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Survival</U>. The respective indemnities, rights of contribution, representations,
warranties and agreements of the Company and the Underwriters contained in this Underwriting Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Underwriting Agreement or any certificate delivered pursuant hereto
shall survive the delivery of and payment for the Securities and shall remain in full force and effect, regardless of any termination of this Underwriting Agreement or any investigation made by or on behalf of the Company or the Underwriters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Information Provided by Underwriters</U>. At Closing, the Underwriters will deliver a
letter to the Company acknowledging the only information relating to any Underwriter that has been furnished to the Company in writing by any Underwriter through the Representatives expressly for use in the Registration Statement and the Prospectus.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Certain Defined Terms</U>. For purposes of this Underwriting Agreement, (a)&nbsp;except where otherwise expressly provided, the
term &#147;affiliate&#148; has the meaning set forth in Rule&nbsp;405 under the Securities Act; (b)&nbsp;the term &#147;business day&#148; means any day other than a day on which banks are permitted or required to be closed in New York City and
(c)&nbsp;the term &#147;subsidiary&#148; has the meaning set forth in Rule&nbsp;405 under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Miscellaneous</U>.
(a)<U>&nbsp;Authority of the Representatives</U><I>. </I>Any action by the Underwriters hereunder may be taken by the Representatives on behalf of the Underwriters, and any such action taken by the Representatives shall be binding upon the
Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Notices</U><I>.</I> All notices and other communications hereunder shall be in writing and shall be deemed to have
been duly given if mailed or transmitted and confirmed by any standard form of telecommunication. Notices to the Underwriters shall be given to the Representatives at Barclays Bank PLC, 1 Churchill Place, London E14 5HP, United Kingdom, Attention:
Debt Syndicate (fax no.: +44 (0) 20 7773 9098); to Merrill Lynch International, at 2 King Edward Street, London, EC1A 1HQ, United Kingdom, Attention: Syndicate Desk (fax no. +44 (0) 20 7995 0048); and to Co&ouml;peratieve Rabobank U.A., Croeselaan
18, 3521CB Utrecht, The Netherlands, Attention: Origination&nbsp;&amp; Syndication/Private Placements (fax no. + 31 30 2918708). Notices to the Company shall be given to it at 412 N. Wells Street, Chicago, Illinois 60654 (fax no. (269) <FONT
STYLE="white-space:nowrap">565-1266);</FONT> Attention: General Counsel, or if different, to the address set forth in this Underwriting Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Contractual Recognition of <FONT STYLE="white-space:nowrap">Bail-In</FONT></U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Notwithstanding and to the exclusion of any other term of this Underwriting Agreement or any other agreements, arrangements, or
understanding between any of the parties hereto, each of the parties acknowledges, accepts and agrees that any BRRD Liability of a BRRD Party hereto arising under this Underwriting Agreement may be subject to the exercise of EU <FONT
STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant Resolution Authority and acknowledges, accepts, and agrees to be bound by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the effect of the exercise of any EU <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant
Resolution Authority in relation to any BRRD Liability of any BRRD Party under this Underwriting Agreement, which exercise (without limitation) may include and result in any of the following, or some combination thereof: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the reduction of all, or a portion, of the BRRD Liability or outstanding amounts due thereon;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the conversion of all, or a portion, of the BRRD Liability into shares, other securities or other obligations
of the BRRD Party or another person (and the issue to or conferral on it of such shares, securities or obligations); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the cancellation of the BRRD Liability; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the amendment or alteration of the amounts due in relation to such BRRD Liability, including any interest, if
applicable, thereon, the maturity or the dates on which any payments are due, including by suspending payment for a temporary period; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the variation of the terms of this Underwriting Agreement, as deemed necessary by the Relevant Resolution
Authority, to give effect to the exercise of any EU <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the Relevant Resolution Authority. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">&#147;Bail-in</FONT> Legislation&#148; means in relation to a member state of the European Economic Area which has
implemented, or which at any time implements, the BRRD, the relevant implementing law, regulation, rule or requirement as described in the EU <FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation Schedule from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;BRRD&#148; means Directive 2014/59/EU (as amended) establishing a framework for the recovery and resolution of credit institutions and investment firms.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;BRRD Liability&#148; means a liability in respect of which the EU <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers in the <FONT
STYLE="white-space:nowrap">Bail-in</FONT> Legislation may be exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;BRRD Party&#148; means any party hereto that is subject to EU <FONT
STYLE="white-space:nowrap">Bail-in</FONT> Powers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;EU <FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation Schedule&#148; means the document
described as such, then in effect, and published by the Loan Market Association (or any successor person) from time to time at <FONT STYLE="white-space:nowrap">https://www.lma.eu.com/documents-guidelines/eu-bail-legislation-schedule.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;EU <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers&#148; means any Write-down and Conversion Powers as defined in the EU <FONT
STYLE="white-space:nowrap">Bail-in</FONT> Legislation Schedule in relation to the relevant <FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Relevant Resolution Authority&#148; means, in relation to any BRRD Party, the resolution authority with the ability to exercise any EU <FONT
STYLE="white-space:nowrap">Bail-in</FONT> Powers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding and to the exclusion of any other term of this Underwriting
Agreement or any other agreements, arrangements, or understanding between any of the parties hereto, each of the parties acknowledges, accepts and agrees that a UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability arising under this
Underwriting Agreement may be subject to the exercise of UK Bail-in Powers by the relevant UK resolution authority and acknowledges, accepts, and agrees to be bound by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the effect of the exercise of UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the relevant UK
resolution authority in relation to any UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability of any party under this Underwriting Agreement, which exercise (without limitation) may include and result in any of the following, or some
combination thereof: </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(A)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the reduction of all, or a portion, of such UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability or
outstanding amounts due thereon; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(B)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the conversion of all, or a portion, of such UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability into
shares, other securities or other obligations of the relevant party or another person (and the issue to or conferral on it of such shares, securities or obligations); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(C)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the cancellation of such UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability; and/or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="16%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(D)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the amendment or alteration of any amount due in relation to such UK
<FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability, including interest, if applicable, thereon, the maturity or the dates on which any payments are due, including by suspending payment for a temporary period; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the variation of the terms of this Underwriting Agreement, as deemed necessary by the relevant UK resolution
authority, to give effect to the exercise of UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers by the relevant UK resolution authority. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation&#148; means Part I of the UK Banking Act 2009 and any other law or regulation applicable
in the UK relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (otherwise than through liquidation, administration or other insolvency proceedings). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Liability&#148; means a liability in respect of which the UK
<FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers may be exercised. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Powers&#148; means the
powers under the UK <FONT STYLE="white-space:nowrap">Bail-in</FONT> Legislation to cancel, transfer or dilute shares issued by a person that is a bank or investment firm or affiliate of a bank or investment firm, to cancel, reduce, modify or change
the form of a liability of such a person or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such
contract or instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) Solely for the purposes of the requirements of 3.2.7R of the FCA Handbook Product Intervention and Product Governance Sourcebook (the
&#147;United Kingdom MiFIR Product Governance Rules&#148;) regarding the mutual responsibilities of manufacturers under the United Kingdom MiFIR Product Governance Rules: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Barclays Bank PLC and Merrill Lynch International (each a &#147;UK Manufacturer&#148; and together the &#147;UK
Manufacturers&#148;) acknowledges that they understand the responsibilities conferred upon them under the United Kingdom MiFIR Product Governance Rules relating to each of the product approval process, the target market and the proposed distribution
channels as applying to the Securities and the related information set out in the Prospectus/announcements in connection with the Securities; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Co&ouml;peratieve Rabobank U.A. and the Company note the application of the United Kingdom MiFIR Product
Governance Rules and acknowledge the target market and distribution channels identified as applying to the Securities by the UK Manufacturers and the related information set out in the Prospectus/announcements in connection with the Securities.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Solely for the purposes of the requirements of Article 9(8) of the MiFID Product Governance rules under EU
Delegated Directive 2017/593 as implemented into the laws of the relevant member state (the &#147;EU Product Governance Rules&#148;) regarding the mutual responsibilities of manufacturers under the EU Product Governance Rules: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Co&ouml;peratieve Rabobank U.A. (the &#147;EU Manufacturer&#148;) acknowledges that it understands the
responsibilities conferred upon it under the Product Governance Rules relating to each of the product approval process, the target market and the proposed distribution channels as applying to the Securities and the related information set out in the
Prospectus in connection with the Securities; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Barclays Bank PLC and the Company note the application of the EU Product Governance Rules and acknowledge the
target market and distribution channels identified as applying to the Securities by the EU Manufacturers and the related information set out in the Prospectus/announcements in connection with the Securities. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Governing Law</U><I>.</I> This Underwriting Agreement shall be governed by and construed in accordance with the laws of the State of
New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Amendments or Waivers</U><I>.</I> No amendment or waiver of any provision of this Underwriting Agreement, nor any
consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>Headings</U><I>.</I> The headings herein are included for convenience of reference only and are not intended to be part of, or to
affect the meaning or interpretation of, this Underwriting Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Counterparts</U>. This Underwriting Agreement may be signed in counterparts (which
may include counterparts delivered by any standard form of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>Recognition of the U.S. Special Resolution Regimes. </U>In the event that any Underwriter that is a Covered Entity becomes subject to a
proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Underwriting Agreement, and any interest and obligation in or under this Underwriting Agreement, will be effective to the same extent as the transfer would
be effective under the U.S. Special Resolution Regime if this Underwriting Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special
Resolution Regime, Default Rights under this Underwriting Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution
Regime if this Underwriting Agreement were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used in this
<U>Section</U><U></U><U>&nbsp;18:</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;BHC Act Affiliate&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be
interpreted in accordance with, 12 U.S.C. &#167; 1841(k). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Covered Entity&#148; means any of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(i) a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">(iii) a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Default Right&#148; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1,
as applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;U.S. Special Resolution Regime&#148; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated
thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding, please indicate your acceptance
of this Underwriting Agreement by signing in the space provided below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">KELLANOVA</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Joel A. Vanderkooi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Joel A. Vanderkooi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Vice President and Treasurer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Accepted: May&nbsp;7, 2024 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Underwriting Agreement]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="78%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Accepted: May&nbsp;7, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: BARCLAYS BANK PLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Lynda Fleming</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Lynda Fleming</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Authorised Signatory</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Underwriting Agreement]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="78%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Accepted: May&nbsp;7, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By: MERRILL LYNCH INTERNATIONAL</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Angus Reynolds</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Angus Reynolds</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Managing Director</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Underwriting Agreement]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Accepted: May&nbsp;7, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By: CO&Ouml;PERATIEVE RABOBANK U.A.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ M. Franken</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: M. Franken</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: ED</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Othmar ter Waarbeek</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Name: Othmar ter Waarbeek</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: ED</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Underwriting Agreement]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Accepted: May&nbsp;7, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: BANCO BILBAO VIZCAYA ARGENTARIA, S.A.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Gonzalo <FONT STYLE="white-space:nowrap">Cid-Luna</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Name: Gonzalo <FONT STYLE="white-space:nowrap">Cid-Luna</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: E.D. &#150; DCM</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Andrea Borna</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Name: Andrea Borna</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: ED &#150; DCM</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Underwriting Agreement]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Accepted: May&nbsp;7, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: HSBC BANK PLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP STYLE="BORDER-BOTTOM:1px solid #000000">/s/ A Kraemer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Name: A Kraemer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: Senior Legal Counsel</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Underwriting Agreement]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Accepted: May&nbsp;7, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: ING BANK N.V., BELGIAN BRANCH</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Kris Devos</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Name: Kris Devos</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: Global Head of Debt Syndicate</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP STYLE="BORDER-BOTTOM:1px solid #000000">/s/ William de Vreede</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Name: William de Vreede</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: Global Head Legal Wholesale Banking</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Underwriting Agreement]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Accepted: May&nbsp;7, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">By: SAMUEL A. RAMIREZ&nbsp;&amp; COMPANY, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" NOWRAP STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Lawrence F. Goldman</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Name: Lawrence F. Goldman</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3">Title: Managing Director</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to
Underwriting Agreement]</I> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule&nbsp;1 </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Principal&nbsp;Amount</B><br><B>of Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Bank PLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 84,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Merrill Lynch International</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Co&ouml;peratieve Rabobank U.A.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">84,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Banco Bilbao Vizcaya Argentaria, S.A.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">HSBC Bank plc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ING Bank N.V., Belgian Branch</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Samuel A. Ramirez&nbsp;&amp; Company, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&#128;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;300,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 2 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Time of Sale Information </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The term sheet set forth in Schedule 3 hereto. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Schedule 3 </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Free Writing Prospectus </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 433 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-279131</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Relating to the Preliminary Prospectus Supplement dated May&nbsp;7, 2024 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>(to Prospectus dated May&nbsp;6, 2024) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#128;300,000,000 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kellanova </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3.750% Senior Notes due 2034 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Pricing Term Sheet </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">May&nbsp;7, 2024 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Issuer:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Kellanova</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Anticipated Ratings*:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[Intentionally Omitted]</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Rank:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Senior, Unsecured</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Principal Amount:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#128;300,000,000</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Offering Format:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">SEC Registered</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Trade Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">May&nbsp;7, 2024</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Settlement Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">May&nbsp;16, 2024 (T+7)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Maturity Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">May&nbsp;16, 2034</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Mid Swaps Yield:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">2.713%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Spread to Mid Swaps:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">+110 bps</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Yield to Maturity:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.813%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Coupon (Interest Rate):</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">3.750%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Price to Public:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">99.484%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Benchmark Bund:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">DBR 2.20% due February&nbsp;15, 2034</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Benchmark Bund Price and Yield:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">97.970%; 2.435%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Spread to Benchmark Bund:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">+137.8 bps</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Listing:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Kellanova intends to apply to list the notes on The New York Stock Exchange under the symbol &#147;K&nbsp;34&#148;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Interest Payment Dates:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Annually on May&nbsp;16, commencing May&nbsp;16, 2025</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Day Count Convention:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">ACTUAL/ACTUAL (ICMA)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Make-Whole Call:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">At any time prior to February&nbsp;16, 2034 (three months prior to the maturity date of the notes) at a discount rate of Comparable Government Bond Rate plus 25 basis points, plus accrued and unpaid interest to the redemption
date</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Par Call Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">At any time prior to February&nbsp;16, 2034 (three months prior to the maturity date of the notes)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Change of Control Offer to Purchase:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If Kellanova experiences a Change of Control Repurchase Event, it will be required, unless it has exercised the right to redeem the notes, to offer to repurchase the notes at a purchase price equal to 101% of their principal amount,
plus accrued and unpaid interest to the repurchase date</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Denominations:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&#128;100,000 and integral multiples of &#128;1,000 in excess thereof</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">ISIN/Common Code/ CUSIP:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">XS2811886584 / 281188658 / 487836 CB2</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="65%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Joint Book-Running Managers:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Barclays Bank PLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Merrill Lynch
International</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Co&ouml;peratieve Rabobank</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Co-Managers:</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Banco Bilbao Vizcaya Argentaria, S.A.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">HSBC Bank
plc</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ING Bank N.V., Belgian Branch</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Samuel A.
Ramirez&nbsp;&amp; Company, Inc.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">MiFID II / UK MiFIR Target Market / PRIIPs / UK PRIIPs:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">MiFID II / UK MiFIR professionals/ECPs-only/No PRIIPs / UK PRIIPs KID &#150; Manufacturer target market (MIFID II product governance / UK MiFIR product governance) is eligible counterparties and professional clients only (all
distribution channels). No PRIIPs / UK PRIIPs key information document (KID) has been prepared as not available to retail investors in the EEA or the United Kingdom.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Stabilization:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">FCA/ICMA</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to
revision or withdrawal at any time.</B> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>It is expected that delivery of the Senior Notes will be made against payment therefore on
or about May&nbsp;16, 2024, which is the seventh business day following the date hereof. Under the E.U. Central Securities Depositaries Regulation, trades in the secondary market generally are required to settle in two London business days, unless
the parties to any such trade expressly agree otherwise. In addition, under Rule <FONT STYLE="white-space:nowrap">15c6-1</FONT> under the U.S. Securities Exchange Act of 1934, trades in the secondary market generally are required to settle in two
New York business days, unless the parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Senior Notes prior to the second business day, as applicable, before the delivery of the Senior Notes will be
required, by virtue of the fact that the Senior Notes initially settle on the seventh business day after the date of the Preliminary Prospectus Supplement, to specify an alternative settlement cycle at the time of any such trade to prevent failed
settlement. Purchasers of the Senior Notes who wish to trade the Senior Notes prior to their date of delivery should consult their own advisors. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you
invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on
the SEC web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Barclays Bank PLC toll-free at <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-888-603-5847;</FONT></FONT></FONT> Co&ouml;peratieve Rabobank U.A. at + 31307121591; or Merrill Lynch International, Toll-free: <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-294-1322.</FONT></FONT></FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Any underwriter
that is not a broker-dealer registered with the Securities and Exchange Commission will only make sales of the Senior Notes in the United States through one or more registered broker-dealers in compliance with applicable securities laws and the
rules of the Financial Industry Regulatory Authority, Inc. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Senior Notes are not intended to be offered, sold or otherwise made available to
and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (the &#147;EEA&#148;). </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For these
purposes, a retail investor means a person who is one (or more) of: (i)&nbsp;a retail client as defined in point (11)&nbsp;of Article 4(1) of Directive 2014/65/EU (as amended, &#147;MiFID II&#148;); or (ii)&nbsp;a customer within the meaning of
Directive (EU) 2016/97 (as amended), where that customer would not qualify as a professional client as defined in point (10)&nbsp;of Article 4(1) of MiFID II. Consequently no key information document required by Regulation (EU) No 1286/2014 (as
amended, the &#147;PRIIPs Regulation&#148;) for offering or selling the Senior Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Senior Notes or otherwise making them
available to any retail investor in the EEA may be unlawful under the PRIIPS Regulation. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Senior Notes are not intended to be offered, sold or otherwise made available to and should not be
offered, sold or otherwise made available to any UK Retail Investor in the United Kingdom. For these purposes, a UK Retail Investor means a person who is one (or more) of: (i)&nbsp;a retail client, as defined in point (8)&nbsp;of Article 2 of
Regulation (EU) No 2017/565 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended, the &#147;EUWA&#148;); or (ii)&nbsp;a customer within the meaning of the provisions of the United Kingdom
Financial Services and Markets Act 2000 (as amended, the &#147;FSMA&#148;) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97 (as amended), where that customer would not qualify as a professional client, as defined
in point (8)&nbsp;of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of United Kingdom domestic law by virtue of the EUWA. Consequently no key information document required by the PRIIPs Regulation as it forms part of domestic law by
virtue of the EUWA (the &#147;UK PRIIPs Regulation&#148;) for offering or selling the Senior Notes or otherwise making them available to UK Retail Investors in the United Kingdom has been prepared and therefore offering or selling the Senior Notes
or otherwise making them available to any UK Retail Investor in the United Kingdom may be unlawful under the UK PRIIPs Regulation. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Solely for the
purposes of each manufacturer&#146;s product approval process, the target market assessment in respect of the Senior Notes has led to the conclusion that: (i)&nbsp;the target market for the Senior Notes is eligible counterparties and professional
clients only, each as defined in MiFID II; and (ii)&nbsp;all channels for distribution of the Senior Notes to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or recommending the Senior
Notes (a &#147;distributor&#148;) should take into consideration the manufacturers&#146; target market assessment; however, a distributor subject to MiFID II is responsible for undertaking its own target market assessment in respect of the Senior
Notes (by either adopting or refining the manufacturers&#146; target market assessment) and determining appropriate distribution channels. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Solely
for the purposes of each manufacturer&#146;s product approval process, the target market assessment in respect of the Senior Notes has led to the conclusion that: (i)&nbsp;the target market for the Senior Notes is only eligible counterparties, as
defined in the FCA Handbook Conduct of Business Sourcebook (&#147;COBS&#148;), and professional clients, as defined in Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA (&#147;UK MiFIR&#148;); and (ii)&nbsp;all
channels for distribution of the Senior Notes to eligible counterparties and professional clients are appropriate. Any distributor should take into consideration the manufacturers&#146; target market assessment; however, a distributor subject to the
FCA Handbook Product Intervention and Product Governance Sourcebook (the &#147;UK MiFIR Product Governance Rules&#148;) is responsible for undertaking its own target market assessment in respect of the Senior Notes (by either adopting or refining
the manufacturers&#146; target market assessment) and determining appropriate distribution channels. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Any disclaimers or other notices that may
appear below are not applicable to this communication and should be disregarded. Such disclaimers were automatically generated as a result of this communication being sent via Bloomberg or another communication system. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">S-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><U>Annex A </U></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Underwriters&#146; Representations and Warranties </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) It has not and will not use, authorize use of, refer to, or participate in the planning for use of, any &#147;free writing
prospectus,&#148; as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company and not incorporated by reference into the Registration Statement and any press release
issued by the Company) other than (i)&nbsp;a free writing prospectus that, solely as a result of use by such Underwriter, would not trigger an obligation to file such free writing prospectus with the Commission or is not required to be retained by
the Company pursuant to Rule 433, (ii) any Issuer Free Writing Prospectus listed on Schedule 3 or prepared pursuant to Section&nbsp;3(c) or Section&nbsp;4(d) above (including any electronic road show), or (iii)&nbsp;any free writing prospectus
prepared by such underwriter and approved by the Company in advance in writing (each such free writing prospectus referred to in clauses (i)&nbsp;or (iii), an &#147;Underwriter Free Writing Prospectus&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It has not used and will not, without the prior written consent of the Company, use any free writing prospectus that contains the final
terms of the Securities unless such terms have previously been included in a free writing prospectus filed with the Commission; <U>provided</U> that the Underwriters may, at any time, use a term sheet substantially in the form of Schedule 3 hereto
without the consent of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) It is not subject to any pending proceeding under Section&nbsp;8A of the Securities Act with
respect to the offering (and will promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery Period). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) It represents and agrees that: (i)&nbsp;it has not offered, sold or otherwise made available and will not offer, sell or otherwise make
available any Securities to any retail investor in the United Kingdom; (ii)&nbsp;it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity
(within the meaning of Section&nbsp;21 of the Financial Services and Markets Act 2000 (as amended, the &#147;FSMA&#148;) received by it in connection with the issue or sale of the Securities in circumstances in which Section&nbsp;21(1) of the FSMA
would not apply to the Company; and (iii)&nbsp;it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the Securities in, from or otherwise involving the United Kingdom. For the
purposes of this Section (d), the expression &#147;retail investor&#148; means a person who is one (or more) of the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) a
retail client, as defined in point (8)&nbsp;of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the EUWA; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) a customer within the meaning of the provisions of the FSMA and any rules or regulations made under the FSMA to implement the Insurance
Distribution Directive (as defined in Section (e)&nbsp;below), where that customer would not qualify as a professional client, as defined in point (8)&nbsp;of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of
the EUWA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Each Underwriter represents and agrees that it has not offered, sold or otherwise made
available and will not offer, sell or otherwise make available any Securities to any retail investor in the European Economic Area. For the purposes of this <U>Section (e)</U>: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the expression &#147;retail investor&#148; means a person who is one (or more) of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(1) a retail client as defined in point (11)&nbsp;of Article 4(1) of MiFID II; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(2) a customer within the meaning of the Insurance Distribution Directive, where that customer would not qualify as a professional client as
defined in point (10)&nbsp;of Article 4(1) of MiFID II; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the expression &#147;MiFID II&#148; means Directive 2014/65/EU, as
amended and the expression &#147;Insurance Distribution Directive&#148; means Directive (EU) 2016/97, as amended. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><U>Annex B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Provided under separate cover </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><U>Annex C </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>Provided under separate cover </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex C-1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>k-20240506.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/10/2024 12:50:20 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:k="http://kellanova.com/20240506"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://kellanova.com/20240506"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" namespace="http://fasb.org/us-gaap/2023" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" namespace="http://fasb.org/us-types/2023" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="k-20240506_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="k-20240506_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="k-20240506_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="k_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="k_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="k_A1.000SeniorNotesDue2024Member" name="A1.000SeniorNotesDue2024Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="k_A1.250SeniorNotesDue2025Member" name="A1.250SeniorNotesDue2025Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember" name="FiveZeroPercentEuroNotesDueTwentyTwentyNineMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>k-20240506_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/10/2024 12:50:22 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="k-20240506.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="k-20240506.xsd#k_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="k_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="k-20240506.xsd#k_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="k_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="k-20240506.xsd#k_A1.000SeniorNotesDue2024Member" xlink:type="locator" xlink:label="k_A1.000SeniorNotesDue2024Member" />
    <link:loc xlink:href="k-20240506.xsd#k_A1.250SeniorNotesDue2025Member" xlink:type="locator" xlink:label="k_A1.250SeniorNotesDue2025Member" />
    <link:loc xlink:href="k-20240506.xsd#k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember" xlink:type="locator" xlink:label="k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="k_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="k_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="k_A1.000SeniorNotesDue2024Member" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="k_A1.250SeniorNotesDue2025Member" order="26" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember" order="27" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="30.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="52.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="53.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>k-20240506_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/10/2024 12:50:20 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="k-20240506.xsd#k_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="k_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="k_DocumentAndEntityInformationTable" xlink:to="k_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="k_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="k_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="k-20240506.xsd#k_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="k_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="k_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="k_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="k_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="k-20240506.xsd#k_A1.000SeniorNotesDue2024Member" xlink:type="locator" xlink:label="k_A1.000SeniorNotesDue2024Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="k_A1.000SeniorNotesDue2024Member" xlink:to="k_A1.000SeniorNotesDue2024Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="k_A1.000SeniorNotesDue2024Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">A 1.000 Senior Notes Due 2024 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="k_A1.000SeniorNotesDue2024Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">A 1.000 Senior Notes Due 2024 [Member]</link:label>
    <link:loc xlink:href="k-20240506.xsd#k_A1.250SeniorNotesDue2025Member" xlink:type="locator" xlink:label="k_A1.250SeniorNotesDue2025Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="k_A1.250SeniorNotesDue2025Member" xlink:to="k_A1.250SeniorNotesDue2025Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="k_A1.250SeniorNotesDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">A 1.250 Senior Notes Due 2025 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="k_A1.250SeniorNotesDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">A 1.250 Senior Notes Due 2025 [Member]</link:label>
    <link:loc xlink:href="k-20240506.xsd#k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember" xlink:type="locator" xlink:label="k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember" xlink:to="k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Five Zero Percent Euro Notes Due Twenty Twenty Nine [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Five Zero Percent Euro Notes Due Twenty Twenty Nine [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>k-20240506_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/10/2024 12:50:20 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="k-20240506.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="k-20240506.xsd#k_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="k_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="k_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="k-20240506.xsd#k_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="k_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationTable" xlink:to="k_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="k-20240506.xsd#k_A1.000SeniorNotesDue2024Member" xlink:type="locator" xlink:label="k_A1.000SeniorNotesDue2024Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="k_A1.000SeniorNotesDue2024Member" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="k-20240506.xsd#k_A1.250SeniorNotesDue2025Member" xlink:type="locator" xlink:label="k_A1.250SeniorNotesDue2025Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="k_A1.250SeniorNotesDue2025Member" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="k-20240506.xsd#k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember" xlink:type="locator" xlink:label="k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="k_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="53.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.u1</span><table class="report" border="0" cellspacing="2" id="idm140417011324624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 06, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_k_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000055067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  06,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Kellanova<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-4171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">38-0710690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">412 N. Wells Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Chicago<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">961-2000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_k_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $.25 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=k_A1.000SeniorNotesDue2024Member', window );">A 1.000 Senior Notes Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_k_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.000% Senior Notes due 2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">K 24<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=k_A1.250SeniorNotesDue2025Member', window );">A 1.250 Senior Notes Due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_k_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.250% Senior Notes due 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">K 25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember', window );">Five Zero Percent Euro Notes Due Twenty Twenty Nine [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_k_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">0.500% Senior Notes due 2029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">K 29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_k_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">k_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>k_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=k_A1.000SeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=k_A1.000SeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=k_A1.250SeniorNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=k_A1.250SeniorNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" !@AZE8J<W(%U\%  "_&P  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;+69:W/B-A2&_XJ&7J:=28(M PEIPDRN+9/+,B%MIKO3#XHM0!/;<B4!X=_W
MR!"+[9HC)AOR(=A@O7XLZ;RO;)_,I7K1$\X-><W27)\V)L84Q\VFCB<\8_I
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MT\!)[*'->"5XOA2D&P3OV(($G3U" ]KZNG43T"H^6O'14B[R\9W5\I$OM]"
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MIR1-\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%
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M>FR-9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@R*2*Y U+2X<L-03&IAJ
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " !@AZE8F5R<(Q &  "<)P  $P
M            @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M &"'J5BIS<@77P4  +\;   8              " @0X(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " !@AZE8GZ ;\+$"  #B#   #0
M            @ &C#0  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( &"'J5B7
MBKL<P    !,"   +              "  7\0  !?<F5L<R\N<F5L<U!+ 0(4
M Q0    ( &"'J5@<.&7J/P$  #P"   /              "  6@1  !X;"]W
M;W)K8F]O:RYX;6Q02P$"% ,4    " !@AZE8)!Z;HJT   #X 0  &@
M        @ '4$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M    " !@AZE899!YDAD!  #/ P  $P              @ &Y$P  6T-O;G1E
C;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   #%0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>5</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>4</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d804742d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="d804742d8k.htm">d804742d8k.htm</File>
    <File>k-20240506.xsd</File>
    <File>k-20240506_def.xml</File>
    <File>k-20240506_lab.xml</File>
    <File>k-20240506_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d804742d8k.htm": {
   "nsprefix": "k",
   "nsuri": "http://kellanova.com/20240506",
   "dts": {
    "inline": {
     "local": [
      "d804742d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "k-20240506.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "k-20240506_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "k-20240506_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "k-20240506_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 3,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 5,
   "entityCount": 1,
   "segmentCount": 4,
   "elementCount": 31,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 31
   },
   "report": {
    "R1": {
     "role": "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-05-06_to_2024-05-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d804742d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-05-06_to_2024-05-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d804742d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "k_A1.000SeniorNotesDue2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kellanova.com/20240506",
     "localname": "A1.000SeniorNotesDue2024Member",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "A 1.000 Senior Notes Due 2024 [Member]",
        "terseLabel": "A 1.000 Senior Notes Due 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "k_A1.250SeniorNotesDue2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kellanova.com/20240506",
     "localname": "A1.250SeniorNotesDue2025Member",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "A 1.250 Senior Notes Due 2025 [Member]",
        "terseLabel": "A 1.250 Senior Notes Due 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "k_DocumentAndEntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://kellanova.com/20240506",
     "localname": "DocumentAndEntityInformationLineItems",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "k_DocumentAndEntityInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://kellanova.com/20240506",
     "localname": "DocumentAndEntityInformationTable",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "k_FiveZeroPercentEuroNotesDueTwentyTwentyNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kellanova.com/20240506",
     "localname": "FiveZeroPercentEuroNotesDueTwentyTwentyNineMember",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Five Zero Percent Euro Notes Due Twenty Twenty Nine [Member]",
        "terseLabel": "Five Zero Percent Euro Notes Due Twenty Twenty Nine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://kellanova.com//20240506/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193125-24-135360-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-135360-xbrl.zip
M4$L#!!0    ( &"'J5CH"-[,QQ0  )>-   .    9#@P-#<T,F0X:RYH=&WM
M7>M7XD@6_]Y_11UZ9T;/$4AXJ*#-'H>V>]RQU2/VSNQ^F5,DA=0:4IFJ1&7^
M^KVW*@D!$D$%M'OL<UI(ZG7KUN^^ZL7A/^]''KEE4G'A?_C)KE@_$>8[PN7^
M]8>?CGK=DY.?_MEY=S@,(1MD]57;9?Q#:1B&0;M:O>]+KZ*84[D6MU5(J-:L
M6KT49XQ4.1P'3*6Y!U3U*T)>5Y.4J>R^\/UHE&:^N[NKZ.JQ@!O**I:H0J8R
MY&*2.TFY>X_[-U/%[NJZD-UJM:HZ-<DZES-MH&99]2HF]ZEB2?9)WAOF>=07
MM[3BB!%2W;":UFY*@>)Y[4.==O7W+Z<]9\A&M,Q]%5+?26N/0EE(2ZL*J4E&
MKD2C9N\]0'B<(RUP7Y37AKP^=)/]_O/EZ21[F)]_DK4:2NJK@9 C&@)0L*9F
MV:J5:[N92LH A*F*$F LJF>_7+=37D+C_*&NSG 14]T90,:9=ZLF,8/':TJ#
M7#AB0A:-Q7A"22BA1##JPD?(0X]U]LN_'E;-UW>'(Q92@L7+[,^(WWXH=84?
M,C\L7P&"2\0Q3Q]*(;L/J[JZ*I2JF@H)(8=]X8X[ARZ_)2H<>^Q#R>4J\.@8
M1825.N20W[<Q-Y/Q=^ZZS#??(<N9D0_BTQ&69;Q]-&*^"__#3QZ]CBFX#R_9
M )(CJ8?B#P1UV8+1V/TC%)FG$N'NAQ*_ORW7K7JI,Z">8H?5J9;F6L82OVBB
M_H#F_SCV@37C+K0OJ7?BN^S^5S8N9>@KR/ X.CL6_FN"7.[-TU>=89-D R9!
MT3$%SRCW;:6E%-I:IUK1+:$B^U!2?!1XZ;NAQ$[>E!/54KE7;I)&I2,%PF!Q
M"]6XJU/=T\]*1-(\:@EKQ[S50[4$;Y-B3(]4^LA=?#'@3!+-/Y8K_]V37Z='
M9[8P4IU;?P##)]ST$41?AA]IR#H3VI*2D[0)K6Y!WB0E;39MISK%G:=QZX]8
MGY1[(32"8M?UJ%+G@UXHG)NC>Z[2'%TQ&@E?O__"1GTF-\#IF%WL&BF+GUUH
M[S[PN,-#0P=Q.21KIZ 4$]LN[$ZIDV29Z\]A-;?Z":<G=/R]$'!3/@)GR[)Z
MS.="GHF0J8\1PRJ^:2#<M!_NUAL>'L)#K3G/N.:WCX<'NO6&AT(\?.*W[+],
MB@L&AML/CR,I$OY=W<&+L?E[!J[U-PZ11_?T.T!-=<8KJV9]^BKX_O"1B0"P
M5)EZ_-IO(XO,8&?2[[@;#MO[E2;W#S)Y/38(#T947G._C-_;A$:A2-Y(?CV,
M7V%U05(91FOE(=.IH,V#M(I0!.W,8U^$H1CI-WTA@?3DC1W<$R4\[I+W&E!6
MJ?/C>WO7.CBL!D4-U1<W5'MR0YEJ&U )F>\ &<#0E!7_B[7M_?1Y0$?<&[>O
M -"*G+$[<BE&U#_0:7>&[K[PW(.<X?EZ=G)U_)'TKHZNCGO%Y%@;(J=WW/UZ
M>7)U<MPC1V<?R?'OW5^.SCX?D^[YER\GO=[)^=FS:*RM@L;?CGJ_G)Q]OCH_
MVR$?NZ1F-1NM&:IFFER$RVDX+)*G7%SN/@F7X ,%X30T#XR,UNP?YON^I(Q.
M.I.HB+SA,H.Q 4Q].K_\0@Y50/U4#0UYR,KPQF$0?]])&I0ZA;,2'X43H9;.
M3(L\85*B =&IGGZ9#OD/JTA7YPT^:X'/2L0=%-+E\=D5N3R^.+^\>GGU<Q%)
M%5$_)*$@/>8@  W'[#H1DMC-+7?[Y:D4 Q(.&1(821YR*']\[PRI?\W(D1,2
M2+9;]48QG1L;7O2$D!S) B%#LI4\,PJ>$%,A8;>0,TYF[G:[>/XRT107VITZ
M-E[6HU6&F79&M1&V771'H?C0I>,Q4,3\K$K9*W6^T+$9_-T=@I7,ZY<WQ;)Z
MQ5)KK )YQ4 R$\V7[)HK7(D(SR#E&:9GO]3Y-5D9RIES?H:JL%;!AZWC>PHJ
M ;MO!#'I-J&*J( Y&-:YA/N$AXJ $@$YE+,J[@W9!<A^#F/>'8:T[S'B 'K0
M6\+5UI)5TL\!==WD.6XJ[JHC &N!8NWDR\,0R> )W3W##-NR?HA9U[9B*MM6
M$@,"75+_=:<#RWKC!UQ;R";<,AERAWHQ5TU'9S/%I6O+E4Y(G,N=K>:P&I,H
MD]2 7K-R7S)Z@VNLW&5M>BL !4MSQ];#,]4BR0"&3"&FK;%"9CH PPZ>;M85
MGA70!QQAHY5.?$=(L(5:_>CYDJZ(_%".N\)]EK'#=5F<Q@A9(,4M-CMM[5I@
MJYE'[\ *%GK1H;O,Z*<0G\V^%G8^.? P_/[$/09I.''V9 O0M$H=N]RP]^Q"
MSGV_#+RB]R?QY*"C.?9L;MJE3GV_;.W9UF[+6H*C:] %^ZM1!4\U_"N)R[>T
M]L"814"H(,G_(%)0+M<1S:.\$GL-Q($CPK.:;ML8UY>0CY<=)%PKY4J]AC%!
M54B,]/YMA^/DLD>.1X$GQKB^\,(#,JU7R9FH3,9%*SWX@P[DM^J/ZOCF.0YI
MJ_5=^X)'KBN94O''*01']C/,:JW4:=@U<E8AO^'XDEXH&0L?\O6^=\9VX>NY
MO!)W_C/86B]UND,@[UK,LG)GT0Q$3(:VT^?R MQRKO<TKLW);S9 J7@090NN
M%NW>*R#V0D#UWG]Y\*1X9$))L]39M7:;.3-JWX)CMP!^6S&S<+XED#"H/* >
M8??,B4)^B],PH-29VD$?R(M0KY*_> #,=-GV' -RE/PC)W)7,HU4" ^4HB,8
MDF<"8A?85MMM;<_C\LD!RJF 8;L8"O_Y$=Y>J=/:M<LURRJ.2)X^T;<:WV4R
MH?GC^_V:O7>@ -L>"Y !Q-<<R"(. GV:0.XYRP0K0=>9",E1@-LX$.LOS\M/
MH%,A9C*3IE*K6'BD1JR!BP-B5EM C:#.)AY5R2+&V]3I>E8;%^$,[3!S;O2Z
M& W _H'FQ0"X+^Y)GWGB#D<-$W%L%VL5O9JL)9L,N(<"PQ5(3\A\%T8]%##P
MH\@+J<]$I+PQ4:!,U&"L6X@+B#[PR_CN\7I=9O(]@GH 4?XX21N ^RSNL!S:
M;HXAH2);BC'RF?E,@@$Y\:%LI -X<E2IF5YMMPOQMOO4 &"E#G[JU4\\_?F0
M8B;D6,KJE_)"@L8/![D&N\A&_"9Y"&.*87CDQY&6>K8+UA?"ZU,8SQ#0E[4C
M^\COUEZC<3!O1A9$V[/1,9D>6O)L/3VS8ZS4B7D#S,@RAP29%?++".#2J#5C
M.,^L2>-2]):]1[J?+DFM;E4@XV,BV#?\+L9O3^BMC]#N%U!VH/&\]8&W]2V!
M=\(8J-IP9AZY"ZV W:!ENY88@@G(IW9;)!!?6%NM855,C=L9K_%-&E8F#1>2
MH2;',T]Z3QD::WD^&#S!]U]6*G:M;TDJ%D(4.%AV,BQ,H+_(!BPA26ZYMM7?
M7JTLF3K?I&D3TG2B5,3D1F3*?I.II62JSLJ-+6>U,A77N;1,K3R,RSB0)EYB
M$B*NH'!?)FJ )(B"[A;'0W^#%9'O>XO.$V9OEYCD*.ABCGR\Z&K@%5XL8+;.
M.D/BX FJS:S2/I6%+\TO25$^#_NRVNF-1Y!M2VUH77L#'%O'K.=9O$54 XS%
M%N3%5\&%3T 6@:*),9BV2:]TA;(P8C?F;6S7^EJD'^E%/>M>@8R+52MU3#K1
M&7;(/RJU)@FH)+?4BQ@)\)SH,'<WX(OL8BMB9RSF1L)?B)?U4B?GZ-&K8E."
MNL0Q?,*>]^=Q:];W1_TRMT"]VP M!%+Y'R%O#"Y33S:7OV_R_Z1;)3(,;T(4
M@7E_("8WT=F)"QH@_\#+JT+UFH7_,8S<!1U 7CW#-J,&%O-M.6VP]Z8--G"G
M2(;A^Z@-(&^^-FB^<G!O0ALLR<B6U@:OG6$;U 8/\FTI;;!GO6F#E[E1)C,&
M=JEC59I%[D+KE>-][0KB6;RM:9WQVGFX*9WQ!%8NIT;J3U CFYCV/O%=7 I@
MI#\FCM[)!#7>D+LAT\=W9K8/<46H3X!YV.@UN9;B+ASBBD* 6XHHB"0; &OT
MN5ZS2<-JDOE; R:7!=3390+$T=Z!WJ^1E.'Z8'" !X-Q.]R2JQ.U?CE=.E_N
MPH+EERIB(G'!8JZ9#+65]>YM7+C3_#@>H,]Z?+IF>-:V;K;7*%PW^_']OMUJ
M'"3T$$,0B2E:-Y=.!@^@%3>EYD*?SVV:&P*PF<><$(#M"[T6%"FF<P$[XZUY
M>+DPUYODS,5;R#[=EC?&QN\X-(U"X@-]D"+9+5=0#L2%^@YN$Z&.@V=N,3->
M,^Q2Z2JS*<]]<"&JOD73A:@LNBLQ\].A*5J?6N:2K24NT?J&;^LRFT3CK:+O
MWN5#DHWF$(FO,NY=G\&8@WOGW=&Q*IE;&-X=#E-/T!&>D.WW+?WO(.E-<)]=
MAZ]J A[>@+O:R]?>S6XR^/G\\N/Q9;E[?GIZ=-$[;B=?7O,F ]O.W65 ]%>
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M''2,0!421&I65\2J=*T%'?J]FJ29:1O4L85@KXUNTJ2=&PSD ,P8=4 AC"[
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M74D\IK )W&Z5Y- O_MFM;)B]ID4UF>A,3*+:KK+J?L]J9E4Z;$Z2%L>P<ZF
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MZ)UM)F6JP0$^%^=6C!Y,6DN)T,6TNW 8R3TE"#)WL D<UG4(NYU;G412I7F
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MQ;YR>""2F8;GP7^ ;V8RL37[&H]P3M=0M6_(\L;;X()+U7"?XHIEECN^XLA
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MI0XOF<C3[PV>;Z[9^;@/8(=<JI0WX*2H9=GUE);5X748'6"YPH](RU7?J-F
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MBYKS=:R8\D5<9.Q/E)X<!G%;$FTH\=%>D7ZRN?4,L[E:5WX(Y\M(VMOH&5
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M!11B.Z%;K-[TKYZ3V*HT$\ML#)EV(G /TLRW(U&6;  ZN>6.:'-$,]:AJS
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M'%5YFIQ<LMN"5YA)P_"%P2,QOJ8TKYFZ@6E-(X-KX5WZJ')T<68P,Z'JC[F
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M8*3:BJDN\?7\!8=X1+3:=I1-SE(R-9D2+T*^-D9""+Y&]>QG<R)0F*BXU=E
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M^](X^ H@7_66MC>WE^<[$]:?#U8&F]O/EW>5A^"?J\>KWOLL/PM2F_F^>W>
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M4:%!K1B[+]:<;_0US:Z2*#Q'RK\0A_FR/*Z5)<1I+$H)$/T(GHQ%O89K#C8
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M[1VEQ(^Z@Q8GTUOH*VLJ06P3M=91G(]F$PS]8X"=J8N]W.15NH*?4DC.KYT
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M^&&WHTABWKMQ<-#N59_I<8R =X7 C02%]&_!%-A:@I@^()VNZ\Q3UQ^J,(2
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M_<JXX+X = E*.]?_I2#)4Y(_@Q56.GPTK4*?MDK_E"JO!?I)I4S?XH<MI]*
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M$UVTI^@* W>8,QW#$BC.HYLT8YNA6)J@7C8#*(01:*.BU0I<!R[,ZG-&1K
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M@ )M GA::R^B*%NF=+>#&R \&M]UP]\3BZJ8X]H:G^79- )9?PB2,IO$(V^
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M,Y3.I+IGOC@N(?$@_MAQS8$OG#T9 UDT5?<4#:MAG9UOIM^+XS[%7K"88>A
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MJBA7W,L4&^(\+4%#>E.M5R&^LW]RR#$,U8=79?6/S/8.K8KD-A$OM8(50<Z
MFP6I^-;J.1UI 2*ZF^E[_3O6:C6_:_4_&O8&@\$=BSB*:TQ8?+9@*L2>V]T:
MK:SW+8WA[MC]5_@VND1,CT#7@K08Z&H@RZ5?X$D"^>OX6?OZ-D=3%O ?'&W[
M.:H)?Z5&6_#;&,/=L4[P[]0EA%_6,G)R1 A_XWXVX7<QM0O^"_[(_F4";YEL
M,DK.%P)S6^,GN6.5_KR6+YCKS,,>LJV,R/[V<:_T_0=ISU)$LZ6J@RH/67U0
M#11P3*OGOU075!/7DO'B$)*Z+^ZXDEOJN[&S73S]AFBYYW]02P,$%     @
M8(>I6.TD2:.Y!0  P#H  !(   !K+3(P,C0P-3 V7W!R92YX;6S5FUUSXC84
MAN]W9O^#ZMZT,S7&$+(-$[)#2;+#-%\3V+:S-QEA'T 366(D$>#?5S)HB\&
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M;"5,Q_QL_GBY/&+>S-\(=<G?4$L! A0#%     @ 8(>I6.@(WLS'%   EXT
M  X              ( !     &0X,#0W-#)D.&LN:'1M4$L! A0#%     @
M8(>I6 ;H\.7*90  ,2P" !               ( !\Q0  &0X,#0W-#)D97@Q
M,2YH=&U02P$"% ,4    " !@AZE8Y'K6L[-[  #QUP( $
M@ 'K>@  9#@P-#<T,F1E>#$R+FAT;5!+ 0(4 Q0    ( &"'J5@M2(KW-00
M .81   .              "  <SV  !K+3(P,C0P-3 V+GAS9%!+ 0(4 Q0
M   ( &"'J5C7--B% @8  +@V   2              "  2W[  !K+3(P,C0P
M-3 V7V1E9BYX;6Q02P$"% ,4    " !@AZE8,0UH>R\(  !C7   $@
M        @ %? 0$ :RTR,#(T,#4P-E]L86(N>&UL4$L! A0#%     @ 8(>I
M6.TD2:.Y!0  P#H  !(              ( !O@D! &LM,C R-# U,#9?<')E
:+GAM;%!+!08     !P ' +0!  "G#P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>d804742d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:k="http://kellanova.com/20240506"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="k-20240506.xsd" xlink:type="simple"/>
    <context id="duration_2024-05-06_to_2024-05-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055067</identifier>
        </entity>
        <period>
            <startDate>2024-05-06</startDate>
            <endDate>2024-05-06</endDate>
        </period>
    </context>
    <context id="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055067</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-06</startDate>
            <endDate>2024-05-06</endDate>
        </period>
    </context>
    <context id="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.000SeniorNotesDue2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055067</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">k:A1.000SeniorNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-06</startDate>
            <endDate>2024-05-06</endDate>
        </period>
    </context>
    <context id="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.250SeniorNotesDue2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055067</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">k:A1.250SeniorNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-06</startDate>
            <endDate>2024-05-06</endDate>
        </period>
    </context>
    <context id="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-FiveZeroPercentEuroNotesDueTwentyTwentyNineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000055067</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">k:FiveZeroPercentEuroNotesDueTwentyTwentyNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-06</startDate>
            <endDate>2024-05-06</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-303">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-05-06_to_2024-05-06"
      id="Hidden_dei_EntityCentralIndexKey">0000055067</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-346">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-347">2024-05-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-348">Kellanova</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-349">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-350">1-4171</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-351">38-0710690</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-352">412 N. Wells Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-353">Chicago</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-354">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-355">60654</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-356">(269)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-357">961-2000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-358">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-359">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-360">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-361">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-362">Common Stock, $.25 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-363">K</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-364">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.000SeniorNotesDue2024Member"
      id="ixv-365">1.000% Senior Notes due 2024</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.000SeniorNotesDue2024Member"
      id="ixv-366">K 24</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.000SeniorNotesDue2024Member"
      id="ixv-367">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.250SeniorNotesDue2025Member"
      id="ixv-368">1.250% Senior Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.250SeniorNotesDue2025Member"
      id="ixv-369">K 25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-A1.250SeniorNotesDue2025Member"
      id="ixv-370">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-FiveZeroPercentEuroNotesDueTwentyTwentyNineMember"
      id="ixv-371">0.500% Senior Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-FiveZeroPercentEuroNotesDueTwentyTwentyNineMember"
      id="ixv-372">K 29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2024-05-06_to_2024-05-06_us-gaap-StatementClassOfStockAxis_k-FiveZeroPercentEuroNotesDueTwentyTwentyNineMember"
      id="ixv-373">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-05-06_to_2024-05-06" id="ixv-374">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
